Daniel Mathalon, PhD, MD

Title(s)Professor, Psychiatry
SchoolSchool of Medicine
Address4150 Clement St, #282
San Francisco CA 94121
Phone415-221-4810 ext. 3860
ORCID ORCID Icon0000-0001-6090-4974 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Stanford UniversityMD1994
    Stanford MedicineResidency1998Psychiatry
    Stanford MedicineFellowship1999Psychophysiology
    Collapse Awards and Honors
    Dept. of Psychology, Indiana University2021Lifetime Achievement Award

    Collapse Overview 
    Collapse Overview
    Dr. Daniel Mathalon is a psychiatrist who cares for patients who have recently developed or are at high risk of developing psychosis.

    Using such methods as magnetic resonance imaging (MRI) and electroencephalography (EEG), Mathalon studies abnormalities in the brains of people with schizophrenia, looking at the range of patients from those who have the high-risk syndrome that sometimes develops into psychosis to those living with chronic psychosis. His current research specifically focuses on improving the ability to diagnose and treat the warning signs of psychosis before the condition fully develops, with a long-term goal of preventing psychosis and improving outcomes for young people with psychosis and their families.

    Mathalon earned his doctorate in psychology at Indiana University and his medical degree at Stanford University School of Medicine, where he also completed a residency in psychiatry and a fellowship in psychophysiology.

    Collapse Research 
    Collapse Research Activities and Funding
    Secondary data analysis of auditory steady-state response to explore the RDoC cognitive system constructs across the psychosis spectrum
    NIH R03MH125226Feb 1, 2021 - Nov 30, 2022
    Role: Co-Principal Investigator
    Improving Frontal Emotion Regulation in PTSD by Targeting Sleep
    NIH R56MH107042Sep 20, 2016 - Nov 30, 2019
    Role: Co-Principal Investigator
    Visual and Motor Neuroplasticity in Schizophrenia
    NIH R21MH102727Jan 1, 2014 - Dec 31, 2016
    Role: Principal Investigator
    Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression
    NIH R01AT004572Apr 1, 2008 - Feb 28, 2015
    Role: Co-Principal Investigator
    Functional Brain Abnormalities in the Schizophrenia Prodrome
    NIH R01MH076989May 21, 2007 - Sep 24, 2014
    Role: Principal Investigator
    9/9-Predictors and Mechanisms of Conversion to Psychosis
    NIH U01MH076989Apr 1, 2006 - Jun 30, 2021
    Role: Principal Investigator
    Calcium Signaling &Prefrontal Deficits in Schizophrenia
    NIH P50MH068789Dec 12, 2003 - Nov 30, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies. Brain Behav Immun. 2024 Mar 29; 119:188-196. Byrne JF, Healy C, Föcking M, Heurich M, Susai SR, Mongan D, Wynne K, Kodosaki E, Woods SW, Cornblatt BA, Stone WS, Mathalon DH, Bearden CE, Cadenhead KS, Addington J, Walker EF, Cannon TD, Cannon M, Jeffries C, Perkins D, Cotter DR. PMID: 38555993.
      View in: PubMed   Mentions:    Fields:    
    2. The hierarchical taxonomy of psychopathology in clinical high risk for psychosis: Validation and extension. J Psychopathol Clin Sci. 2024 Mar 28. Williams TF, Williams AL, Cowan HR, Walker EF, Cannon TD, Bearden CE, Keshavan M, Cornblatt BA, Addington J, Woods SW, Perkins DO, Mathalon DH, Cadenhead KS, Stone WS, Mittal VA. PMID: 38546628.
      View in: PubMed   Mentions:    Fields:    
    3. Spectral graph model for fMRI: a biophysical, connectivity-based generative model for the analysis of frequency-resolved resting state fMRI. bioRxiv. 2024 Mar 27. Raj A, Sipes BS, Verma P, Mathalon DH, Biswal BB, Nagarajan SS. PMID: 38586057; PMCID: PMC10996488.
      View in: PubMed   Mentions:
    4. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophr Bull. 2024 Mar 07. Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, Cecci G, Chen EYH, Cho KIK, Choi J, Clark SR, Coleman MJ, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Dwyer D, Ebdrup BH, Ellman LM, Fusar-Poli P, Galindo L, Gaspar PA, Gerber C, Glenthøj LB, Glynn R, Harms MP, Horton LE, Kahn RS, Kambeitz J, Kambeitz-Ilankovic L, Kane JM, Kapur T, Keshavan MS, Kim SW, Koutsouleris N, Kubicki M, Kwon JS, Langbein K, Lewandowski KE, Light GA, Mamah D, Marcy PJ, Mathalon DH, McGorry PD, Mittal VA, Nordentoft M, Nunez A, Pasternak O, Pearlson GD, Perez J, Perkins DO, Powers AR, Roalf DR, Sabb FW, Schiffman J, Shah JL, Smesny S, Spark J, Stone WS, Strauss GP, Tamayo Z, Torous J, Upthegrove R, Vangel M, Verma S, Wang J, Rossum IW, Wolf DH, Wolff P, Wood SJ, Yung AR, Agurto C, Alvarez-Jimenez M, Amminger P, Armando M, Asgari-Targhi A, Cahill J, Carrión RE, Castro E, Cetin-Karayumak S, Mallar Chakravarty M, Cho YT, Cotter D, D'Alfonso S, Ennis M, Fadnavis S, Fonteneau C, Gao C, Gupta T, Gur RE, Gur RC, Hamilton HK, Hoftman GD, Jacobs GR, Jarcho J, Ji JL, Kohler CG, Lalousis PA, Lavoie S, Lepage M, Liebenthal E, Mervis J, Murty V, Nicholas SC, Ning L, Penzel N, Poldrack R, Polosecki P, Pratt DN, Rabin R, Rahimi Eichi H, Rathi Y, Reichenberg A, Reinen J, Rogers J, Ruiz-Yu B, Scott I, Seitz-Holland J, Srihari VH, Srivastava A, Thompson A, Turetsky BI, Walsh BC, Whitford T, Wigman JTW, Yao B, Yuen HP, Ahmed U, Byun AJS, Chung Y, Do K, Hendricks L, Huynh K, Jeffries C, Lane E, Langholm C, Lin E, Mantua V, Santorelli G, Ruparel K, Zoupou E, Adasme T, Addamo L, Adery L, Ali M, Auther A, Aversa S, Baek SH, Bates K, Bathery A, Bayer JMM, Beedham R, Bilgrami Z, Birch S, Bonoldi I, Borders O, Borgatti R, Brown L, Bruna A, Carrington H, Castillo-Passi RI, Chen J, Cheng N, Ching AE, Clifford C, Colton BL, Contreras P, Corral S, Damiani S, Done M, Estradé A, Etuka BA, Formica M, Furlan R, Geljic M, Germano C, Getachew R, Goncalves M, Haidar A, Hartmann J, Jo A, John O, Kerins S, Kerr M, Kesselring I, Kim H, Kim N, Kinney K, Krcmar M, Kotler E, Lafanechere M, Lee C, Llerena J, Markiewicz C, Matnejl P, Maturana A, Mavambu A, Mayol-Troncoso R, McDonnell A, McGowan A, McLaughlin D, McIlhenny R, McQueen B, Mebrahtu Y, Mensi M, Hui CLM, Suen YN, Wong SMY, Morrell N, Omar M, Partridge A, Phassouliotis C, Pichiecchio A, Politi P, Porter C, Provenzani U, Prunier N, Raj J, Ray S, Rayner V, Reyes M, Reynolds K, Rush S, Salinas C, Shetty J, Snowball C, Tod S, Turra-Fariña G, Valle D, Veale S, Whitson S, Wickham A, Youn S, Zamorano F, Zavaglia E, Zinberg J, Woods SW, Shenton ME. PMID: 38451304.
      View in: PubMed   Mentions:    Fields:    
    5. Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk. Mol Psychiatry. 2024 Feb 09. Zhu Y, Maikusa N, Radua J, Sämann PG, Fusar-Poli P, Agartz I, Andreassen OA, Bachman P, Baeza I, Chen X, Choi S, Corcoran CM, Ebdrup BH, Fortea A, Garani RR, Glenthøj BY, Glenthøj LB, Haas SS, Hamilton HK, Hayes RA, He Y, Heekeren K, Kasai K, Katagiri N, Kim M, Kristensen TD, Kwon JS, Lawrie SM, Lebedeva I, Lee J, Loewy RL, Mathalon DH, McGuire P, Mizrahi R, Mizuno M, Møller P, Nemoto T, Nordholm D, Omelchenko MA, Raghava JM, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Smigielski L, Sugranyes G, Takahashi T, Tamnes CK, Tang J, Theodoridou A, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TAMJ, Waltz JA, Westlye LT, Zhou JH, Thompson PM, Hernaus D, Jalbrzikowski M, Koike S, ENIGMA Clinical High Risk for Psychosis Working Group. PMID: 38332374.
      View in: PubMed   Mentions:    Fields:    
    6. P300 in schizophrenia: Then and now. Biol Psychol. 2024 Feb 03; 187:108757. Hamilton HK, Mathalon DH, Ford JM. PMID: 38316196.
      View in: PubMed   Mentions:    Fields:    
    7. Pons-to-Cerebellum Hypoconnectivity Along the Psychosis Spectrum and Associations With Sensory Prediction and Hallucinations in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Feb 02. Abram SV, Hua JPY, Nicholas S, Roach B, Keedy S, Sweeney JA, Mathalon DH, Ford JM. PMID: 38311290.
      View in: PubMed   Mentions:    Fields:    
    8. Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study. Schizophr Bull. 2024 Jan 19. Byrne JF, Healy C, Föcking M, Susai SR, Mongan D, Wynne K, Kodosaki E, Heurich M, de Haan L, Hickie IB, Smesny S, Thompson A, Markulev C, Young AR, Schäfer MR, Riecher-Rössler A, Mossaheb N, Berger G, Schlögelhofer M, Nordentoft M, Chen EYH, Verma S, Nieman DH, Woods SW, Cornblatt BA, Stone WS, Mathalon DH, Bearden CE, Cadenhead KS, Addington J, Walker EF, Cannon TD, Cannon M, McGorry P, Amminger P, Cagney G, Nelson B, Jeffries C, Perkins D, Cotter DR. PMID: 38243809.
      View in: PubMed   Mentions:    Fields:    
    9. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms. Brain Behav Immun. 2024 03; 117:175-180. Healy C, Byrne J, Raj Suasi S, Föcking M, Mongan D, Kodosaki E, Heurich M, Cagney G, Wynne K, Bearden CE, Woods SW, Cornblatt B, Mathalon D, Stone W, Cannon TD, Addington J, Cadenhead KS, Perkins D, Jeffries C, Cotter D. PMID: 38219978.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis. JAMA Psychiatry. 2024 Jan 01; 81(1):77-88. ENIGMA Clinical High Risk for Psychosis Working Group, Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, Glenthøj LB, Haut KM, Hayes RA, Heekeren K, Hooker CI, Hwang WJ, Jahanshad N, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Koike S, Kristensen TD, Kwon JS, Lawrie SM, Lebedeva I, Lee J, Lemmers-Jansen ILJ, Lin A, Ma X, Mathalon DH, McGuire P, Michel C, Mizrahi R, Mizuno M, Møller P, Mora-Durán R, Nelson B, Nemoto T, Nordentoft M, Nordholm D, Omelchenko MA, Pantelis C, Pariente JC, Raghava JM, Reyes-Madrigal F, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Smigielski L, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Theodoridou A, Thomopoulos SI, Thompson PM, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TAMJ, van Erp TGM, Waltz JA, Wenneberg C, Westlye LT, Wood SJ, Zhou JH, Hernaus D, Jalbrzikowski M, Kahn RS, Corcoran CM, Frangou S. PMID: 37819650; PMCID: PMC10568447.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Notice of Retraction: Worthington MA et al. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. JAMA Psychiatry. 2023;80(10):1017-1025. JAMA Psychiatry. 2024 Jan 01; 81(1):109-110. Cannon TD, Worthington MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Lympus CA, Mathalon DH, Perkins DO, Stone WS, Walker EF, Woods SW, Zhao Y. PMID: 37917049.
      View in: PubMed   Mentions:    Fields:    
    12. Linking enlarged choroid plexus with plasma analyte and structural phenotypes in clinical high risk for psychosis: A multisite neuroimaging study. Brain Behav Immun. 2024 03; 117:70-79. Bannai D, Reuter M, Hegde R, Hoang D, Adhan I, Gandu S, Pong S, Raymond N, Zeng V, Chung Y, He G, Sun D, van Erp TGM, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Jeffries C, Stone W, Tsuang M, Walker E, Woods SW, Cannon TD, Perkins D, Keshavan M, Lizano P. PMID: 38169244.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Relations of Lifetime Perceived Stress and Basal Cortisol With Hippocampal Volume Among Healthy Adolescents and Those at Clinical High Risk for Psychosis: A Structural Equation Modeling Approach. Biol Psychiatry. 2023 Dec 12. Aberizk K, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Walker EF, Ku BS. PMID: 38092185.
      View in: PubMed   Mentions:    Fields:    
    14. Spatial Dynamic Subspaces Encode Sex-Specific Schizophrenia Disruptions in Transient Network Overlap and Their Links to Genetic Risk. Biol Psychiatry. 2023 Dec 07. Iraji A, Chen J, Lewis N, Faghiri A, Fu Z, Agcaoglu O, Kochunov P, Adhikari BM, Mathalon DH, Pearlson GD, Macciardi F, Preda A, van Erp TGM, Bustillo JR, Díaz-Caneja CM, Andrés-Camazón P, Dhamala M, Adali T, Calhoun VD. PMID: 38070846.
      View in: PubMed   Mentions:    Fields:    
    15. Association of Childhood Area-Level Ethnic Density and Psychosis Risk Among Ethnoracial Minoritized Individuals in the US. JAMA Psychiatry. 2023 12 01; 80(12):1226-1234. Anglin DM, Espinosa A, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone W, Tsuang M, Woods SW, Walker E, Bearden CE, Ku BS. PMID: 37585191; PMCID: PMC10433142.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Associations Between Childhood Area-Level Social Fragmentation, Maladaptation to School, and Social Functioning Among Healthy Youth and Those at Clinical High Risk for Psychosis. Schizophr Bull. 2023 11 29; 49(6):1437-1446. Ku BS, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Compton MT, Cornblatt BA, Druss BG, Gülöksüz S, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Carrión RE. PMID: 37358832; PMCID: PMC10686327.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Identifying canonical and replicable multi-scale intrinsic connectivity networks in 100k+ resting-state fMRI datasets. Hum Brain Mapp. 2023 12 01; 44(17):5729-5748. Iraji A, Fu Z, Faghiri A, Duda M, Chen J, Rachakonda S, DeRamus T, Kochunov P, Adhikari BM, Belger A, Ford JM, Mathalon DH, Pearlson GD, Potkin SG, Preda A, Turner JA, van Erp TGM, Bustillo JR, Yang K, Ishizuka K, Faria A, Sawa A, Hutchison K, Osuch EA, Theberge J, Abbott C, Mueller BA, Zhi D, Zhuo C, Liu S, Xu Y, Salman M, Liu J, Du Y, Sui J, Adali T, Calhoun VD. PMID: 37787573; PMCID: PMC10619392.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. JAMA Psychiatry. 2023 10 01; 80(10):1017-1025. Worthington MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Lympus CA, Mathalon DH, Perkins DO, Stone WS, Walker EF, Woods SW, Zhao Y, Cannon TD. PMID: 37531131; PMCID: PMC10398543.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. The Scanner as the Stimulus: Deficient Gamma-BOLD Coupling in Schizophrenia at Rest. Schizophr Bull. 2023 09 07; 49(5):1364-1374. Jacob MS, Sargent K, Roach BJ, Shamshiri EA, Mathalon DH, Ford JM. PMID: 37098100; PMCID: PMC10483456.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses. Mol Psychiatry. 2023 Oct; 28(10):4363-4373. Banaj N, Vecchio D, Piras F, De Rossi P, Bustillo J, Ciufolini S, Dazzan P, Di Forti M, Dickie EW, Ford JM, Fuentes-Claramonte P, Gruber O, Guerrero-Pedraza A, Hamilton HK, Howells FM, Kraemer B, Lawrie SM, Mathalon DH, Murray R, Pomarol-Clotet E, Potkin SG, Preda A, Radua J, Richter A, Salvador R, Sawa A, Scheffler F, Sim K, Spaniel F, Stein DJ, Temmingh HS, Thomopoulos SI, Tomecek D, Uhlmann A, Voineskos A, Yang K, Jahanshad N, Thompson PM, Van Erp TGM, Turner JA, Spalletta G, Piras F. PMID: 37644174; PMCID: PMC10827665.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Improving prediction of psychosis in youth at clinical high-risk: pre-baseline symptom duration and cortical thinning as moderators of the NAPLS2 risk calculator. Psychol Med. 2024 Feb; 54(3):611-619. Worthington MA, Collins MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Walker EF, Woods SW, Cannon TD. PMID: 37642172.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. Early Interv Psychiatry. 2023 Aug 28. Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Marcy PJ, Allott K, Amminger P, Arango C, Broome MR, Cadenhead KS, Chen EYH, Choi J, Conus P, Cornblatt BA, Glenthøj LB, Horton LE, Kambeitz J, Kapur T, Keshavan MS, Koutsouleris N, Langbein K, Lavoie S, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pasternak O, Pearlson GD, Gaspar PA, Shah JL, Smesny S, Stone WS, Strauss GP, Wang J, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, Yung AR, Accelerating Medicines Partnership Schizophrenia. PMID: 37641537; PMCID: PMC10899527.
      View in: PubMed   Mentions: 1     Fields:    
    23. Auditory oddball hypoactivation in schizophrenia. Psychiatry Res Neuroimaging. 2023 10; 335:111710. Nakahara S, Male AG, Turner JA, Calhoun VD, Lim KO, Mueller BA, Bustillo JR, O'Leary DS, Voyvodic J, Belger A, Preda A, Mathalon DH, Ford JM, Guffanti G, Macciardi F, Potkin SG, Van Erp TGM. PMID: 37690161.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Aberrant Hierarchical Prediction Errors Are Associated With Transition to Psychosis: A Computational Single-Trial Analysis of the Mismatch Negativity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 12; 8(12):1176-1185. Hauke DJ, Charlton CE, Schmidt A, Griffiths JD, Woods SW, Ford JM, Srihari VH, Roth V, Diaconescu AO, Mathalon DH. PMID: 37536567.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Spatial Dynamic Subspaces Encode Sex-Specific Schizophrenia Disruptions in Transient Network Overlap and its Links to Genetic Risk. bioRxiv. 2023 Jul 19. Iraji A, Chen J, Lewis N, Faghiri A, Fu Z, Agcaoglu O, Kochunov P, Adhikari BM, Mathalon DH, Pearlson GD, Macciardi F, Preda A, van Erp TGM, Bustillo JR, Díaz-Caneja CM, Andrés-Camazón P, Dhamala M, Adali T, Calhoun VD. PMID: 37503085; PMCID: PMC10370141.
      View in: PubMed   Mentions:
    26. Associations between childhood ethnoracial minority density, cortical thickness, and social engagement among minority youth at clinical high-risk for psychosis. Neuropsychopharmacology. 2023 11; 48(12):1707-1715. Ku BS, Collins M, Anglin DM, Diomino AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Druss BG, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Walker EF. PMID: 37438421; PMCID: PMC10579230.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Alterations in grey matter structure linked to frequency-specific cortico-subcortical connectivity in schizophrenia via multimodal data fusion. bioRxiv. 2023 Jul 06. Duda M, Faghiri A, Belger A, Bustillo JR, Ford JM, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Sui J, Van Erp TGM, Calhoun VD. PMID: 37461731; PMCID: PMC10350020.
      View in: PubMed   Mentions:
    28. Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status. Schizophr Bull Open. 2023 Jan; 4(1):sgad014. Tran T, Spilka MJ, Raugh IM, Strauss GP, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, Woods SW, Addington JM. PMID: 37362552; PMCID: PMC10287168.
      View in: PubMed   Mentions:
    29. The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis. Front Psychiatry. 2023; 14:1125168. Devoe DJ, Lui L, Cannon TD, Cadenhead KS, Cornblatt BA, Keshavan M, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. PMID: 37293402; PMCID: PMC10244495.
      View in: PubMed   Mentions:
    30. Multi-model order spatially constrained ICA reveals highly replicable group differences and consistent predictive results from resting data: A large N fMRI schizophrenia study. Neuroimage Clin. 2023; 38:103434. Meng X, Iraji A, Fu Z, Kochunov P, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson G, Potkin SG, Preda A, Turner J, van Erp TGM, Sui J, Calhoun VD. PMID: 37209635; PMCID: PMC10209454.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. medRxiv. 2023 May 02. Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, Yung AR, Accelerating Medicines Partnership Schizophrenia. PMID: 37205422; PMCID: PMC10187348.
      View in: PubMed   Mentions:
    32. Cortical and subcortical brain morphometry abnormalities in youth at clinical high-risk for psychosis and individuals with early illness schizophrenia. Psychiatry Res Neuroimaging. 2023 07; 332:111653. Hua JPY, Loewy RL, Stuart B, Fryer SL, Niendam TA, Carter CS, Vinogradov S, Mathalon DH. PMID: 37121090; PMCID: PMC10362971.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis. Front Psychiatry. 2023; 14:1143315. Amir CM, Kapler S, Hoftman GD, Kushan L, Zinberg J, Cadenhead KS, Kennedy L, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD, Addington J, Bearden CE. PMID: 37151981; PMCID: PMC10157227.
      View in: PubMed   Mentions: 1  
    34. Sampling from different populations: Sociodemographic, clinical, and functional differences between samples of first episode psychosis individuals and clinical high-risk individuals who progressed to psychosis. Schizophr Res. 2023 05; 255:239-245. Hagler MA, Ferrara M, Yoviene Sykes LA, Li F, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, Powers AR, Allen AR, Srihari VH, Woods SW. PMID: 37028205; PMCID: PMC10207144.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium. Proc Natl Acad Sci U S A. 2023 04 04; 120(14):e2213880120. Schijven D, Postema MC, Fukunaga M, Matsumoto J, Miura K, de Zwarte SMC, van Haren NEM, Cahn W, Hulshoff Pol HE, Kahn RS, Ayesa-Arriola R, Ortiz-García de la Foz V, Tordesillas-Gutierrez D, Vázquez-Bourgon J, Crespo-Facorro B, Alnæs D, Dahl A, Westlye LT, Agartz I, Andreassen OA, Jönsson EG, Kochunov P, Bruggemann JM, Catts SV, Michie PT, Mowry BJ, Quidé Y, Rasser PE, Schall U, Scott RJ, Carr VJ, Green MJ, Henskens FA, Loughland CM, Pantelis C, Weickert CS, Weickert TW, de Haan L, Brosch K, Pfarr JK, Ringwald KG, Stein F, Jansen A, Kircher TTJ, Nenadic I, Krämer B, Gruber O, Satterthwaite TD, Bustillo J, Mathalon DH, Preda A, Calhoun VD, Ford JM, Potkin SG, Chen J, Tan Y, Wang Z, Xiang H, Fan F, Bernardoni F, Ehrlich S, Fuentes-Claramonte P, Garcia-Leon MA, Guerrero-Pedraza A, Salvador R, Sarró S, Pomarol-Clotet E, Ciullo V, Piras F, Vecchio D, Banaj N, Spalletta G, Michielse S, van Amelsvoort T, Dickie EW, Voineskos AN, Sim K, Ciufolini S, Dazzan P, Murray RM, Kim WS, Chung YC, Andreou C, Schmidt A, Borgwardt S, McIntosh AM, Whalley HC, Lawrie SM, du Plessis S, Luckhoff HK, Scheffler F, Emsley R, Grotegerd D, Lencer R, Dannlowski U, Edmond JT, Rootes-Murdy K, Stephen JM, Mayer AR, Antonucci LA, Fazio L, Pergola G, Bertolino A, Díaz-Caneja CM, Janssen J, Lois NG, Arango C, Tomyshev AS, Lebedeva I, Cervenka S, Sellgren CM, Georgiadis F, Kirschner M, Kaiser S, Hajek T, Skoch A, Spaniel F, Kim M, Kwak YB, Oh S, Kwon JS, James A, Bakker G, Knöchel C, Stäblein M, Oertel V, Uhlmann A, Howells FM, Stein DJ, Temmingh HS, Diaz-Zuluaga AM, Pineda-Zapata JA, López-Jaramillo C, Homan S, Ji E, Surbeck W, Homan P, Fisher SE, Franke B, Glahn DC, Gur RC, Hashimoto R, Jahanshad N, Luders E, Medland SE, Thompson PM, Turner JA, van Erp TGM, Francks C. PMID: 36976765; PMCID: PMC10083554.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    36. Rich-club connectivity and structural connectome organization in youth at clinical high-risk for psychosis and individuals with early illness schizophrenia. Schizophr Res. 2023 05; 255:110-121. Hua JPY, Cummings J, Roach BJ, Fryer SL, Loewy RL, Stuart BK, Ford JM, Vinogradov S, Mathalon DH. PMID: 36989668; PMCID: PMC10705845.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Mismatch Negativity and Theta Oscillations Evoked by Auditory Deviance in Early Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 12; 8(12):1186-1196. Hua JPY, Roach BJ, Ford JM, Mathalon DH. PMID: 36931469.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis. Schizophr Bull. 2023 03 15; 49(2):350-363. Sefik E, Boamah M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan MS, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Cannon TD, Walker EF. PMID: 36394426; PMCID: PMC10016422.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers. Schizophr Res. 2023 04; 254:178-189. Cecchi M, Adachi M, Basile A, Buhl DL, Chadchankar H, Christensen S, Christian E, Doherty J, Fadem KC, Farley B, Forman MS, Honda S, Johannesen J, Kinon BJ, Klamer D, Marino MJ, Missling C, O'Donnell P, Piser T, Puryear CB, Quirk MC, Rotte M, Sanchez C, Smith DG, Uslaner JM, Javitt DC, Keefe RSE, Mathalon D, Potter WZ, Walling DP, Ereshefsky L. PMID: 36921403.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Sleep Spindles Favor Emotion Regulation Over Memory Consolidation of Stressors in Posttraumatic Stress Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 09; 8(9):899-908. Natraj N, Neylan TC, Yack LM, Metzler TJ, Woodward SH, Hubachek SQ, Dukes C, Udupa NS, Mathalon DH, Richards A. PMID: 36889539.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosis. Schizophr Res. 2023 04; 254:125-132. Michaels TI, Carrión RE, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, Woods SW, Cornblatt BA. PMID: 36857950; PMCID: PMC10106391.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Reliability and clinical utility of spatially constrained estimates of intrinsic functional networks from very short fMRI scans. Hum Brain Mapp. 2023 04 15; 44(6):2620-2635. Duda M, Iraji A, Ford JM, Lim KO, Mathalon DH, Mueller BA, Potkin SG, Preda A, Van Erp TGM, Calhoun VD. PMID: 36840728; PMCID: PMC10028646.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Hippocampal Connectivity with the Default Mode Network is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals. Clin Psychol Sci. 2023 Sep; 11(5):801-818. Aberizk K, Sefik E, Addington J, Anticevic A, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Walker EF. PMID: 37981950; PMCID: PMC10656030.
      View in: PubMed   Mentions:
    44. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis. bioRxiv. 2023 Jan 18. Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, Glenthøj LB, Haut KM, Hayes RA, Heekeren K, Hooker CI, Hwang WJ, Jahanshad N, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Koike S, Kristensen TD, Kwon JS, Lawrie SM, Lee J, Lemmers-Jansen IL, Lin A, Ma X, Mathalon DH, McGuire P, Michel C, Mizrahi R, Mizuno M, Møller P, Mora-Durán R, Nelson B, Nemoto T, Nordentoft M, Nordholm D, Omelchenko MA, Pantelis C, Pariente JC, Raghava JM, Reyes-Madrigal F, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Smigielski L, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Theodoridou A, Thomopoulos SI, Thompson PM, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TA, van Erp TG, Waltz JA, Wenneberg C, Westlye LT, Wood SJ, Zhou JH, Hernaus D, Jalbrzikowski M, Kahn RS, Corcoran CM, Frangou S, ENIGMA Clinical High Risk for Psychosis Working Group. PMID: 36711551; PMCID: PMC9882206.
      View in: PubMed   Mentions:
    45. Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in Schizophrenia. Psychiatry Res Neuroimaging. 2023 03; 329:111597. Cheon EJ, Male AG, Gao B, Adhikari BM, Edmond JT, Hare SM, Belger A, Potkin SG, Bustillo JR, Mathalon DH, Ford JM, Lim KO, Mueller BA, Preda A, O'Leary D, Strauss GP, Ahmed AO, Thompson PM, Jahanshad N, Kochunov P, Calhoun VD, Turner JA, van Erp TGM. PMID: 36680843.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. A method for estimating and characterizing explicitly nonlinear dynamic functional network connectivity in resting-state fMRI data. J Neurosci Methods. 2023 04 01; 389:109794. Motlaghian SM, Vahidi V, Belger A, Bustillo JR, Faghiri A, Ford JM, Iraji A, Lim K, Mathalon DH, Miller R, Mueller BA, O'Leary D, Potkin SG, Preda A, van Erp TG, Calhoun VD. PMID: 36652974.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium. Early Interv Psychiatry. 2023 08; 17(8):759-770. Tronick LN, Mirzakhanian H, Addington J, Bearden CE, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. PMID: 36627192.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Alpha Event-Related Desynchronization During Reward Processing in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 05; 8(5):551-559. Fryer SL, Marton TF, Roach BJ, Holroyd CB, Abram SV, Lau KJ, Ford JM, McQuaid JR, Mathalon DH. PMID: 37045705.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Probing long-term potentiation-like visual cortical plasticity in humans using repeated visual stimulation: effects on visual evoked potentials. Neuropsychopharmacology. 2023 01; 48(1):217-218. Hamilton HK, Mathalon DH. PMID: 35974074; PMCID: PMC9700823.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Advanced brain age correlates with greater rumination and less mindfulness in schizophrenia. Neuroimage Clin. 2023; 37:103301. Abram SV, Roach BJ, Hua JPY, Han LKM, Mathalon DH, Ford JM, Fryer SL. PMID: 36586360; PMCID: PMC9830317.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk. Mol Psychiatry. 2023 03; 28(3):1182-1189. Collins MA, Ji JL, Chung Y, Lympus CA, Afriyie-Agyemang Y, Addington JM, Goodyear BG, Bearden CE, Cadenhead KS, Mirzakhanian H, Tsuang MT, Cornblatt BA, Carrión RE, Keshavan M, Stone WS, Mathalon DH, Perkins DO, Walker EF, Woods SW, Powers AR, Anticevic A, Cannon TD. PMID: 36434057; PMCID: PMC10005940.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    52. Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 study. Soc Psychiatry Psychiatr Epidemiol. 2023 Apr; 58(4):559-568. Barbato M, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD, Addington J. PMID: 36348056.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    53. Dysfunctional Cortical Gradient Topography in Treatment-Resistant Major Depressive Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 09; 8(9):928-939. Pasquini L, Fryer SL, Eisendrath SJ, Segal ZV, Lee AJ, Brown JA, Saggar M, Mathalon DH. PMID: 36754677; PMCID: PMC10150583.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. Phase Delay of the 40 Hz Auditory Steady-State Response Localizes to Left Auditory Cortex in Schizophrenia. Clin EEG Neurosci. 2023 Jul; 54(4):370-378. Roach BJ, Hirano Y, Ford JM, Spencer KM, Mathalon DH. PMID: 36213937; PMCID: PMC10311936.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. The Association Between Neighborhood Poverty and Hippocampal Volume Among Individuals at Clinical High-Risk for Psychosis: The Moderating Role of Social Engagement. Schizophr Bull. 2022 09 01; 48(5):1032-1042. Ku BS, Aberizk K, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Carrión RE, Compton MT, Cornblatt BA, Druss BG, Mathalon DH, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 35689540; PMCID: PMC9434451.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis. Schizophr Res. 2022 10; 248:114-121. Santesteban-Echarri O, Liu L, Miller M, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, Woods SW, Addington J. PMID: 36030758.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    57. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort. Schizophr Res. 2022 10; 248:89-97. Duncan E, Roach BJ, Massa N, Hamilton HK, Bachman PM, Belger A, Carrion RE, Johannesen JK, Light GA, Niznikiewicz MA, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Tsuang M, Walker EF, Woods SW, Nasiri N, Mathalon DH. PMID: 35994912; PMCID: PMC10091223.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis. JAMA Psychiatry. 2022 08 01; 79(8):780-789. Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrión RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Cannon TD, Mathalon DH. PMID: 35675082; PMCID: PMC9178501.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    59. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis. Transl Psychiatry. 2022 07 26; 12(1):297. Baldwin H, Radua J, Antoniades M, Haas SS, Frangou S, Agartz I, Allen P, Andreassen OA, Atkinson K, Bachman P, Baeza I, Bartholomeusz CF, Chee MWL, Colibazzi T, Cooper RE, Corcoran CM, Cropley VL, Ebdrup BH, Fortea A, Glenthøj LB, Hamilton HK, Haut KM, Hayes RA, He Y, Heekeren K, Kaess M, Kasai K, Katagiri N, Kim M, Kindler J, Klaunig MJ, Koike S, Koppel A, Kristensen TD, Bin Kwak Y, Kwon JS, Lawrie SM, Lebedeva I, Lee J, Lin A, Loewy RL, Mathalon DH, Michel C, Mizrahi R, Møller P, Nelson B, Nemoto T, Nordholm D, Omelchenko MA, Pantelis C, Raghava JM, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Smigielski L, Sugranyes G, Suzuki M, Takahashi T, Tamnes CK, Tang J, Theodoridou A, Thomopoulos SI, Tomyshev AS, Uhlhaas PJ, Værnes TG, van Amelsvoort TAMJ, Van Erp TGM, Waltz JA, Westlye LT, Wood SJ, Zhou JH, McGuire P, Thompson PM, Jalbrzikowski M, Hernaus D, Fusar-Poli P, ENIGMA Clinical High Risk for Psychosis Working Group. PMID: 35882855; PMCID: PMC9325730.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    60. Path analysis: A method to estimate altered pathways in time-varying graphs of neuroimaging data. Netw Neurosci. 2022 Jul; 6(3):634-664. Falakshahi H, Rokham H, Fu Z, Iraji A, Mathalon DH, Ford JM, Mueller BA, Preda A, van Erp TGM, Turner JA, Plis S, Calhoun VD. PMID: 36204419; PMCID: PMC9531579.
      View in: PubMed   Mentions: 1  
    61. Nonlinear functional network connectivity in resting functional magnetic resonance imaging data. Hum Brain Mapp. 2022 10 15; 43(15):4556-4566. Motlaghian SM, Belger A, Bustillo JR, Ford JM, Iraji A, Lim K, Mathalon DH, Mueller BA, O'Leary D, Pearlson G, Potkin SG, Preda A, van Erp TGM, Calhoun VD. PMID: 35762454; PMCID: PMC9491296.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    62. Multi-spatial-scale dynamic interactions between functional sources reveal sex-specific changes in schizophrenia. Netw Neurosci. 2022 Jun; 6(2):357-381. Iraji A, Faghiri A, Fu Z, Rachakonda S, Kochunov P, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, van Erp TGM, Calhoun VD. PMID: 35733435; PMCID: PMC9208002.
      View in: PubMed   Mentions: 13  
    63. Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia. Mol Psychiatry. 2022 05; 27(5):2448-2456. Abram SV, Roach BJ, Fryer SL, Calhoun VD, Preda A, van Erp TGM, Bustillo JR, Lim KO, Loewy RL, Stuart BK, Krystal JH, Ford JM, Mathalon DH. PMID: 35422467; PMCID: PMC9135621.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    64. Psychological Dimensions Relevant to Motivation and Pleasure in Schizophrenia. Front Behav Neurosci. 2022; 16:827260. Abram SV, Weittenhiller LP, Bertrand CE, McQuaid JR, Mathalon DH, Ford JM, Fryer SL. PMID: 35401135; PMCID: PMC8985863.
      View in: PubMed   Mentions: 1  
    65. Predicting Functional Connectivity From Observed and Latent Structural Connectivity via Eigenvalue Mapping. Front Neurosci. 2022; 16:810111. Cummings JA, Sipes B, Mathalon DH, Raj A. PMID: 35368264; PMCID: PMC8964629.
      View in: PubMed   Mentions: 3  
    66. Virtual Ontogeny of Cortical Growth Preceding Mental Illness. Biol Psychiatry. 2022 08 15; 92(4):299-313. Patel Y, Shin J, Abé C, Agartz I, Alloza C, Alnæs D, Ambrogi S, Antonucci LA, Arango C, Arolt V, Auzias G, Ayesa-Arriola R, Banaj N, Banaschewski T, Bandeira C, Basgöze Z, Cupertino RB, Bau CHD, Bauer J, Baumeister S, Bernardoni F, Bertolino A, Bonnin CDM, Brandeis D, Brem S, Bruggemann J, Bülow R, Bustillo JR, Calderoni S, Calvo R, Canales-Rodríguez EJ, Cannon DM, Carmona S, Carr VJ, Catts SV, Chenji S, Chew QH, Coghill D, Connolly CG, Conzelmann A, Craven AR, Crespo-Facorro B, Cullen K, Dahl A, Dannlowski U, Davey CG, Deruelle C, Díaz-Caneja CM, Dohm K, Ehrlich S, Epstein J, Erwin-Grabner T, Eyler LT, Fedor J, Fitzgerald J, Foran W, Ford JM, Fortea L, Fuentes-Claramonte P, Fullerton J, Furlong L, Gallagher L, Gao B, Gao S, Goikolea JM, Gotlib I, Goya-Maldonado R, Grabe HJ, Green M, Grevet EH, Groenewold NA, Grotegerd D, Gruber O, Haavik J, Hahn T, Harrison BJ, Heindel W, Henskens F, Heslenfeld DJ, Hilland E, Hoekstra PJ, Hohmann S, Holz N, Howells FM, Ipser JC, Jahanshad N, Jakobi B, Jansen A, Janssen J, Jonassen R, Kaiser A, Kaleda V, Karantonis J, King JA, Kircher T, Kochunov P, Koopowitz SM, Landén M, Landrø NI, Lawrie S, Lebedeva I, Luna B, Lundervold AJ, MacMaster FP, Maglanoc LA, Mathalon DH, McDonald C, McIntosh A, Meinert S, Michie PT, Mitchell P, Moreno-Alcázar A, Mowry B, Muratori F, Nabulsi L, Nenadic I, O'Gorman Tuura R, Oosterlaan J, Overs B, Pantelis C, Parellada M, Pariente JC, Pauli P, Pergola G, Piarulli FM, Picon F, Piras F, Pomarol-Clotet E, Pretus C, Quidé Y, Radua J, Ramos-Quiroga JA, Rasser PE, Reif A, Retico A, Roberts G, Rossell S, Rovaris DL, Rubia K, Sacchet M, Salavert J, Salvador R, Sarró S, Sawa A, Schall U, Scott R, Selvaggi P, Silk T, Sim K, Skoch A, Spalletta G, Spaniel F, Stein DJ, Steinsträter O, Stolicyn A, Takayanagi Y, Tamm L, Tavares M, Teumer A, Thiel K, Thomopoulos SI, Tomecek D, Tomyshev AS, Tordesillas-Gutiérrez D, Tosetti M, Uhlmann A, Van Rheenen T, Vazquez-Bourgón J, Vernooij MW, Vieta E, Vilarroya O, Weickert C, Weickert T, Westlye LT, Whalley H, Willinger D, Winter A, Wittfeld K, Yang TT, Yoncheva Y, Zijlmans JL, Hoogman M, Franke B, van Rooij D, Buitelaar J, Ching CRK, Andreassen OA, Pozzi E, Veltman D, Schmaal L, van Erp TGM, Turner J, Castellanos FX, Pausova Z, Thompson P, Paus T. PMID: 35489875.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    67. Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis. Schizophr Bull. 2022 03 01; 48(2):395-404. Worthington MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Stone WS, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 34581405; PMCID: PMC8886593.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Family history of psychosis in youth at clinical high risk: A replication study. Psychiatry Res. 2022 05; 311:114480. Santesteban-Echarri O, Sandel D, Liu L, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, Woods SW, Addington J. PMID: 35245743.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Moving beyond the 'CAP' of the Iceberg: Intrinsic connectivity networks in fMRI are continuously engaging and overlapping. Neuroimage. 2022 05 01; 251:119013. Iraji A, Faghiri A, Fu Z, Kochunov P, Adhikari BM, Belger A, Ford JM, McEwen S, Mathalon DH, Pearlson GD, Potkin SG, Preda A, Turner JA, Van Erp TGM, Chang C, Calhoun VD. PMID: 35189361; PMCID: PMC9107614.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Longitudinal impact of trauma in the North American Prodrome Longitudinal Study-3. Early Interv Psychiatry. 2022 11; 16(11):1211-1216. Farris MS, Braun A, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Stone WS, Tsuang MT, Walker EF, Woods SW, Cannon TD, Addington J. PMID: 35152553; PMCID: PMC9374846.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes. Psychol Med. 2023 Jun; 53(8):3644-3651. Deng W, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Cannon TD. PMID: 35144716; PMCID: PMC10277760.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort. Soc Psychiatry Psychiatr Epidemiol. 2022 Jul; 57(7):1379-1388. Braun A, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD, Addington J. PMID: 35113189.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    73. Sleep Disturbance in Individuals at Clinical High Risk for Psychosis. Schizophr Bull. 2022 01 21; 48(1):111-121. Zaks N, Velikonja T, Parvaz MA, Zinberg J, Done M, Mathalon DH, Addington J, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, Perkins D, Stone WS, Tsuang M, Walker E, Woods SW, Keshavan MS, Buysse DJ, Velthorst E, Bearden CE. PMID: 34536012; PMCID: PMC8781348.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    74. The associations between area-level residential instability and gray matter volumes from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophr Res. 2022 03; 241:1-9. Ku BS, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Compton MT, Cornblatt BA, Druss BG, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Walker EF. PMID: 35066429; PMCID: PMC8960350.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    75. The relationship of fear-potentiated startle and polysomnography-measured sleep in trauma-exposed men and women with and without PTSD: testing REM sleep effects and exploring the roles of an integrative measure of sleep, PTSD symptoms, and biological sex. Sleep. 2022 01 11; 45(1). Richards A, Inslicht SS, Yack LM, Metzler TJ, Russell Huie J, Straus LD, Dukes C, Hubachek SQ, Felmingham KL, Mathalon DH, Woodward SH, Neylan TC. PMID: 34792165.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Ruminative reflection is associated with anticorrelations between the orbitofrontal cortex and the default mode network in depression: implications for repetitive transcranial magnetic stimulation. Brain Imaging Behav. 2022 Jun; 16(3):1186-1195. Ehrlich TJ, Bhat J, Horwege AM, Mathalon DH, Glover GH, Roach BJ, Badran BW, Forman SD, George MS, Scott JC, Thase ME, Yesavage JA, Yurgelun-Todd DA, Rosen AC. PMID: 34860349; PMCID: PMC9107429.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    77. ENIGMA + COINSTAC: Improving Findability, Accessibility, Interoperability, and Re-usability. Neuroinformatics. 2022 01; 20(1):261-275. Turner JA, Calhoun VD, Thompson PM, Jahanshad N, Ching CRK, Thomopoulos SI, Verner E, Strauss GP, Ahmed AO, Turner MD, Basodi S, Ford JM, Mathalon DH, Preda A, Belger A, Mueller BA, Lim KO, van Erp TGM. PMID: 34846691; PMCID: PMC9149142.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    78. Multimodel Order Independent Component Analysis: A Data-Driven Method for Evaluating Brain Functional Network Connectivity Within and Between Multiple Spatial Scales. Brain Connect. 2022 09; 12(7):617-628. Meng X, Iraji A, Fu Z, Kochunov P, Belger A, Ford J, McEwen S, Mathalon DH, Mueller BA, Pearlson G, Potkin SG, Preda A, Turner J, Erp TV, Sui J, Calhoun VD. PMID: 34541879; PMCID: PMC9529308.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    79. Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis. Psychiatr Res Clin Pract. 2021; 3(4):163-171. Deng W, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Joormann J, Cannon T. PMID: 36101655; PMCID: PMC9175802.
      View in: PubMed   Mentions: 1  
    80. Aperiodic measures of neural excitability are associated with anticorrelated hemodynamic networks at rest: A combined EEG-fMRI study. Neuroimage. 2021 12 15; 245:118705. Jacob MS, Roach BJ, Sargent KS, Mathalon DH, Ford JM. PMID: 34798229.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    81. Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression. Brain Stimul. 2022 Jan-Feb; 15(1):63-72. Cardenas VA, Bhat JV, Horwege AM, Ehrlich TJ, Lavacot J, Mathalon DH, Glover GH, Roach BJ, Badran BW, Forman SD, George MS, Thase ME, Yesavage JA, Yurgelun-Todd D, Rosen AC. PMID: 34767967; PMCID: PMC8900427.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    82. Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophr Res. 2021 12; 238:137-144. Ku BS, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Compton MT, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Walker EF, Woods SW, Druss BG. PMID: 34673386; PMCID: PMC10800030.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    83. A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium. Hum Brain Mapp. 2022 01; 43(1):352-372. Gutman BA, van Erp TGM, Alpert K, Ching CRK, Isaev D, Ragothaman A, Jahanshad N, Saremi A, Zavaliangos-Petropulu A, Glahn DC, Shen L, Cong S, Alnaes D, Andreassen OA, Doan NT, Westlye LT, Kochunov P, Satterthwaite TD, Wolf DH, Huang AJ, Kessler C, Weideman A, Nguyen D, Mueller BA, Faziola L, Potkin SG, Preda A, Mathalon DH, Bustillo J, Calhoun V, Ford JM, Walton E, Ehrlich S, Ducci G, Banaj N, Piras F, Piras F, Spalletta G, Canales-Rodríguez EJ, Fuentes-Claramonte P, Pomarol-Clotet E, Radua J, Salvador R, Sarró S, Dickie EW, Voineskos A, Tordesillas-Gutiérrez D, Crespo-Facorro B, Setién-Suero E, van Son JM, Borgwardt S, Schönborn-Harrisberger F, Morris D, Donohoe G, Holleran L, Cannon D, McDonald C, Corvin A, Gill M, Filho GB, Rosa PGP, Serpa MH, Zanetti MV, Lebedeva I, Kaleda V, Tomyshev A, Crow T, James A, Cervenka S, Sellgren CM, Fatouros-Bergman H, Agartz I, Howells F, Stein DJ, Temmingh H, Uhlmann A, de Zubicaray GI, McMahon KL, Wright M, Cobia D, Csernansky JG, Thompson PM, Turner JA, Wang L. PMID: 34498337; PMCID: PMC8675416.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    84. Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial. Early Interv Psychiatry. 2022 06; 16(6):632-642. Miklowitz DJ, Addington JM, O'Brien MP, Denenny DM, Weintraub MJ, Zinberg JL, Mathalon DH, Cornblatt BA, Friedman-Yakoobian MS, Stone WS, Cadenhead KS, Woods SW, Sugar CA, Cannon TD, Bearden CE. PMID: 34427047; PMCID: PMC8863959.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    85. Anxiety in youth at clinical high-risk for psychosis: A two-year follow-up. Schizophr Res. 2021 10; 236:87-88. Santesteban-Echarri O, Liu L, Cadenhead KS, Tsuang MT, Cannon TD, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J. PMID: 34425382.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    86. Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression. Psychopharmacology (Berl). 2021 Nov; 238(11):3229-3237. Pennybaker S, Roach BJ, Fryer SL, Badathala A, Wallace AW, Mathalon DH, Marton TF. PMID: 34363507.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    87. Tri-Clustering Dynamic Functional Network Connectivity Identifies Significant Schizophrenia Effects Across Multiple States in Distinct Subgroups of Individuals. Brain Connect. 2022 02; 12(1):61-73. Rahaman MA, Damaraju E, Turner JA, van Erp TGM, Mathalon D, Vaidya J, Muller B, Pearlson G, Calhoun VD. PMID: 34049447; PMCID: PMC8867091.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    88. Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis. Neuroimage Clin. 2021; 31:102757. Collins MA, Chung Y, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 34273790; PMCID: PMC8283423.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    89. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort. Biol Psychiatry. 2021 11 01; 90(9):632-642. Koutsouleris N, Worthington M, Dwyer DB, Kambeitz-Ilankovic L, Sanfelici R, Fusar-Poli P, Rosen M, Ruhrmann S, Anticevic A, Addington J, Perkins DO, Bearden CE, Cornblatt BA, Cadenhead KS, Mathalon DH, McGlashan T, Seidman L, Tsuang M, Walker EF, Woods SW, Falkai P, Lencer R, Bertolino A, Kambeitz J, Schultze-Lutter F, Meisenzahl E, Salokangas RKR, Hietala J, Brambilla P, Upthegrove R, Borgwardt S, Wood S, Gur RE, McGuire P, Cannon TD. PMID: 34482951; PMCID: PMC8500930.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    90. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis. JAMA Psychiatry. 2021 07 01; 78(7):753-766. ENIGMA Clinical High Risk for Psychosis Working Group, Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, Fusar-Poli P, Uhlhaas PJ, Takahashi T, Sugranyes G, Kwak YB, Mathalon DH, Katagiri N, Hooker CI, Smigielski L, Colibazzi T, Via E, Tang J, Koike S, Rasser PE, Michel C, Lebedeva I, Hegelstad WTV, de la Fuente-Sandoval C, Waltz JA, Mizrahi R, Corcoran CM, Resch F, Tamnes CK, Haas SS, Lemmers-Jansen ILJ, Agartz I, Allen P, Amminger GP, Andreassen OA, Atkinson K, Bachman P, Baeza I, Baldwin H, Bartholomeusz CF, Borgwardt S, Catalano S, Chee MWL, Chen X, Cho KIK, Cooper RE, Cropley VL, Dolz M, Ebdrup BH, Fortea A, Glenthøj LB, Glenthøj BY, de Haan L, Hamilton HK, Harris MA, Haut KM, He Y, Heekeren K, Heinz A, Hubl D, Hwang WJ, Kaess M, Kasai K, Kim M, Kindler J, Klaunig MJ, Koppel A, Kristensen TD, Kwon JS, Lawrie SM, Lee J, León-Ortiz P, Lin A, Loewy RL, Ma X, McGorry P, McGuire P, Mizuno M, Møller P, Moncada-Habib T, Muñoz-Samons D, Nelson B, Nemoto T, Nordentoft M, Omelchenko MA, Oppedal K, Ouyang L, Pantelis C, Pariente JC, Raghava JM, Reyes-Madrigal F, Roach BJ, Røssberg JI, Rössler W, Salisbury DF, Sasabayashi D, Schall U, Schiffman J, Schlagenhauf F, Schmidt A, Sørensen ME, Suzuki M, Theodoridou A, Tomyshev AS, Tor J, Værnes TG, Velakoulis D, Venegoni GD, Vinogradov S, Wenneberg C, Westlye LT, Yamasue H, Yuan L, Yung AR, van Amelsvoort TAMJ, Turner JA, van Erp TGM, Thompson PM, Hernaus D. PMID: 33950164; PMCID: PMC8100913.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    91. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Mol Psychiatry. 2021 11; 26(11):6833-6844. Di Biase MA, Cetin-Karayumak S, Lyall AE, Zalesky A, Cho KIK, Zhang F, Kubicki M, Rathi Y, Lyons MG, Bouix S, Billah T, Anticevic A, Schleifer C, Adkinson BD, Ji JL, Tamayo Z, Addington J, Bearden CE, Cornblatt BA, Keshavan MS, Mathalon DH, McGlashan TH, Perkins DO, Cadenhead KS, Tsuang MT, Woods SW, Stone WS, Shenton ME, Cannon TD, Pasternak O. PMID: 34024906; PMCID: PMC8611104.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    92. Cannabis Use Among Patients With Psychotic Disorders. Perm J. 2021 05 12; 25. Hirschtritt ME, Young-Wolff KC, Mathalon DH, Satre DD. PMID: 35348056; PMCID: PMC8817909.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    93. Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High Risk for Psychosis and Healthy Control Subjects. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 02; 7(2):171-179. Aberizk K, Collins MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Cannon TD, Walker EF. PMID: 33930604; PMCID: PMC8551305.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    94. Targeting location relates to treatment response in active but not sham rTMS stimulation. Brain Stimul. 2021 May-Jun; 14(3):703-709. Rosen AC, Bhat JV, Cardenas VA, Ehrlich TJ, Horwege AM, Mathalon DH, Roach BJ, Glover GH, Badran BW, Forman SD, George MS, Thase ME, Yurgelun-Todd D, Sughrue ME, Doyen SP, Nicholas PJ, Scott JC, Tian L, Yesavage JA. PMID: 33866020; PMCID: PMC8884259.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    95. Brain Density Clustering Analysis: A New Approach to Brain Functional Dynamics. Front Neurosci. 2021; 15:621716. Faghiri A, Damaraju E, Belger A, Ford JM, Mathalon D, McEwen S, Mueller B, Pearlson G, Preda A, Turner JA, Vaidya JG, Van Erp T, Calhoun VD. PMID: 33927587; PMCID: PMC8076753.
      View in: PubMed   Mentions: 1  
    96. Response to targeted cognitive training may be neuroprotective in patients with early schizophrenia. Psychiatry Res Neuroimaging. 2021 06 30; 312:111285. Ramsay IS, Fryer S, Roach BJ, Boos A, Fisher M, Loewy R, Ford JM, Vinogradov S, Mathalon DH. PMID: 33865147; PMCID: PMC8137670.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    97. Cross-paradigm connectivity: reliability, stability, and utility. Brain Imaging Behav. 2021 Apr; 15(2):614-629. Cao H, Chen OY, McEwen SC, Forsyth JK, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 32361945; PMCID: PMC8378905.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    98. Aberrant Dynamic Functional Connectivity of Default Mode Network in Schizophrenia and Links to Symptom Severity. Front Neural Circuits. 2021; 15:649417. Sendi MSE, Zendehrouh E, Ellis CA, Liang Z, Fu Z, Mathalon DH, Ford JM, Preda A, van Erp TGM, Miller RL, Pearlson GD, Turner JA, Calhoun VD. PMID: 33815070; PMCID: PMC8013735.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    99. Sparse deep neural networks on imaging genetics for schizophrenia case-control classification. Hum Brain Mapp. 2021 06 01; 42(8):2556-2568. Chen J, Li X, Calhoun VD, Turner JA, van Erp TGM, Wang L, Andreassen OA, Agartz I, Westlye LT, Jönsson E, Ford JM, Mathalon DH, Macciardi F, O'Leary DS, Liu J, Ji S. PMID: 33724588; PMCID: PMC8090768.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    100. Theta Phase Synchrony Is Sensitive to Corollary Discharge Abnormalities in Early Illness Schizophrenia but Not in the Psychosis Risk Syndrome. Schizophr Bull. 2021 03 16; 47(2):415-423. Roach BJ, Ford JM, Loewy RL, Stuart BK, Mathalon DH. PMID: 32793958; PMCID: PMC7965080.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    101. Thalamic dysconnectivity in the psychosis risk syndrome and early illness schizophrenia. Psychol Med. 2021 Mar 15; 1-9. Fryer SL, Ferri JM, Roach BJ, Loewy RL, Stuart BK, Anticevic A, Ford JM, Mathalon DH. PMID: 33719985.
      View in: PubMed   Mentions: 5     Fields:    
    102. Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study. Schizophr Res. 2021 04; 230:26-37. Jacob MS, Roach BJ, Hamilton HK, Carrión RE, Belger A, Duncan E, Johannesen J, Keshavan M, Loo S, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Stone W, Tsuang M, Walker EF, Woods SW, Mathalon DH. PMID: 33667856; PMCID: PMC8328744.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. Vocalizing and singing reveal complex patterns of corollary discharge function in schizophrenia. Int J Psychophysiol. 2021 06; 164:30-40. Ford JM, Roach BJ, Mathalon DH. PMID: 33621618.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    104. Electrophysiological investigation of reward anticipation and outcome evaluation during slot machine play. Neuroimage. 2021 05 15; 232:117874. Fryer SL, Roach BJ, Holroyd CB, Paulus MP, Sargent K, Boos A, Ford JM, Mathalon DH. PMID: 33609667.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    105. Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study. Front Psychiatry. 2021; 12:591127. Foss-Feig JH, Guillory SB, Roach BJ, Velthorst E, Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington JM, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan T, Perkins D, Seidman LJ, Stone WS, Tsuang M, Walker EF, Woods S, Bearden CE, Mathalon DH. PMID: 33633603; PMCID: PMC7901571.
      View in: PubMed   Mentions: 6  
    106. Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis. Dev Psychopathol. 2021 02; 33(1):53-64. Velikonja T, Velthorst E, Zinberg J, Cannon TD, Cornblatt BA, Perkins DO, Cadenhead KS, Tsuang MT, Addington J, Woods SW, McGlashan T, Mathalon DH, Stone W, Keshavan M, Seidman L, Bearden CE. PMID: 31959269.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    107. Reward Processing in Novelty Seekers: A Transdiagnostic Psychiatric Imaging Biomarker. Biol Psychiatry. 2021 10 15; 90(8):529-539. Qi S, Schumann G, Bustillo J, Turner JA, Jiang R, Zhi D, Fu Z, Mayer AR, Vergara VM, Silva RF, Iraji A, Chen J, Damaraju E, Ma X, Yang X, Stevens M, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, Potkin SG, Preda A, Zhuo C, Xu Y, Chu C, Banaschewski T, Barker GJ, Bokde ALW, Quinlan EB, Desrivières S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Martinot JL, Paillère Martinot ML, Artiges E, Nees F, Orfanos DP, Paus T, Poustka L, Hohmann S, Fröhner JH, Smolka MN, Walter H, Whelan R, Calhoun VD, Sui J, IMAGEN Consortium. PMID: 33875230; PMCID: PMC8322149.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    108. Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD. Transl Psychiatry. 2021 01 28; 11(1):80. Olde Loohuis LM, Mennigen E, Ori APS, Perkins D, Robinson E, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Keshavan MS, Stone WS, Tsuang MT, Walker EF, Woods SW, Cannon TD, Gur RC, Gur RE, Bearden CE, Ophoff RA. PMID: 33510130; PMCID: PMC7844241.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    109. Multiple overlapping dynamic patterns of the visual sensory network in schizophrenia. Schizophr Res. 2021 02; 228:103-111. Sendi MSE, Pearlson GD, Mathalon DH, Ford JM, Preda A, van Erp TGM, Calhoun VD. PMID: 33434723.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    110. The association between migrant status and transition in an ultra-high risk for psychosis population. Soc Psychiatry Psychiatr Epidemiol. 2021 Jun; 56(6):943-952. O'Donoghue B, Geros H, Sizer H, Addington J, Amminger GP, Beaden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Berger GE, Chen EYH, de Haan L, Hartmann JA, Hickie IB, Ising HK, Lavoie S, Lin A, Markulev C, Mathalon DH, McGlashan TH, Mifsud NG, Mossaheb N, Nieman DH, Nordentoft M, Perkins DO, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Seidman LJ, Smesny S, Thompson A, Tsuang MT, van der Gaag M, Verma S, Walker EF, Wood SJ, Woods SW, Yuen HP, Yung AR, McGorry PD, Nelson B. PMID: 33399885.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    111. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. JAMA Psychiatry. 2021 Jan 01; 78(1):47-63. Writing Committee for the Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Bipolar Disorder, Major Depressive Disorder, Obsessive-Compulsive Disorder, and Schizophrenia ENIGMA Working Groups, Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abé C, Anticevic A, Alda M, Aleman A, Alloza C, Alonso-Lana S, Ameis SH, Anagnostou E, McIntosh AA, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, Ayesa-Arriola R, Bakker G, Banaj N, Banaschewski T, Bandeira CE, Baranov A, Bargalló N, Bau CHD, Baumeister S, Baune BT, Bellgrove MA, Benedetti F, Bertolino A, Boedhoe PSW, Boks M, Bollettini I, Del Mar Bonnin C, Borgers T, Borgwardt S, Brandeis D, Brennan BP, Bruggemann JM, Bülow R, Busatto GF, Calderoni S, Calhoun VD, Calvo R, Canales-Rodríguez EJ, Cannon DM, Carr VJ, Cascella N, Cercignani M, Chaim-Avancini TM, Christakou A, Coghill D, Conzelmann A, Crespo-Facorro B, Cubillo AI, Cullen KR, Cupertino RB, Daly E, Dannlowski U, Davey CG, Denys D, Deruelle C, Di Giorgio A, Dickie EW, Dima D, Dohm K, Ehrlich S, Ely BA, Erwin-Grabner T, Ethofer T, Fair DA, Fallgatter AJ, Faraone SV, Fatjó-Vilas M, Fedor JM, Fitzgerald KD, Ford JM, Frodl T, Fu CHY, Fullerton JM, Gabel MC, Glahn DC, Roberts G, Gogberashvili T, Goikolea JM, Gotlib IH, Goya-Maldonado R, Grabe HJ, Green MJ, Grevet EH, Groenewold NA, Grotegerd D, Gruber O, Gruner P, Guerrero-Pedraza A, Gur RE, Gur RC, Haar S, Haarman BCM, Haavik J, Hahn T, Hajek T, Harrison BJ, Harrison NA, Hartman CA, Whalley HC, Heslenfeld DJ, Hibar DP, Hilland E, Hirano Y, Ho TC, Hoekstra PJ, Hoekstra L, Hohmann S, Hong LE, Höschl C, Høvik MF, Howells FM, Nenadic I, Jalbrzikowski M, James AC, Janssen J, Jaspers-Fayer F, Xu J, Jonassen R, Karkashadze G, King JA, Kircher T, Kirschner M, Koch K, Kochunov P, Kohls G, Konrad K, Krämer B, Krug A, Kuntsi J, Kwon JS, Landén M, Landrø NI, Lazaro L, Lebedeva IS, Leehr EJ, Lera-Miguel S, Lesch KP, Lochner C, Louza MR, Luna B, Lundervold AJ, MacMaster FP, Maglanoc LA, Malpas CB, Portella MJ, Marsh R, Martyn FM, Mataix-Cols D, Mathalon DH, McCarthy H, McDonald C, McPhilemy G, Meinert S, Menchón JM, Minuzzi L, Mitchell PB, Moreno C, Morgado P, Muratori F, Murphy CM, Murphy D, Mwangi B, Nabulsi L, Nakagawa A, Nakamae T, Namazova L, Narayanaswamy J, Jahanshad N, Nguyen DD, Nicolau R, O'Gorman Tuura RL, O'Hearn K, Oosterlaan J, Opel N, Ophoff RA, Oranje B, García de la Foz VO, Overs BJ, Paloyelis Y, Pantelis C, Parellada M, Pauli P, Picó-Pérez M, Picon FA, Piras F, Piras F, Plessen KJ, Pomarol-Clotet E, Preda A, Puig O, Quidé Y, Radua J, Ramos-Quiroga JA, Rasser PE, Rauer L, Reddy J, Redlich R, Reif A, Reneman L, Repple J, Retico A, Richarte V, Richter A, Rosa PGP, Rubia KK, Hashimoto R, Sacchet MD, Salvador R, Santonja J, Sarink K, Sarró S, Satterthwaite TD, Sawa A, Schall U, Schofield PR, Schrantee A, Seitz J, Serpa MH, Setién-Suero E, Shaw P, Shook D, Silk TJ, Sim K, Simon S, Simpson HB, Singh A, Skoch A, Skokauskas N, Soares JC, Soreni N, Soriano-Mas C, Spalletta G, Spaniel F, Lawrie SM, Stern ER, Stewart SE, Takayanagi Y, Temmingh HS, Tolin DF, Tomecek D, Tordesillas-Gutiérrez D, Tosetti M, Uhlmann A, van Amelsvoort T, van der Wee NJA, van der Werff SJA, van Haren NEM, van Wingen GA, Vance A, Vázquez-Bourgon J, Vecchio D, Venkatasubramanian G, Vieta E, Vilarroya O, Vives-Gilabert Y, Voineskos AN, Völzke H, von Polier GG, Walton E, Weickert TW, Weickert CS, Weideman AS, Wittfeld K, Wolf DH, Wu MJ, Yang TT, Yang K, Yoncheva Y, Yun JY, Cheng Y, Zanetti MV, Ziegler GC, Franke B, Hoogman M, et al. PMID: 32857118; PMCID: PMC7450410.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    112. A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale. Early Interv Psychiatry. 2021 10; 15(5):1315-1325. Keefe RSE, Woods SW, Cannon TD, Ruhrmann S, Mathalon DH, McGuire P, Rosenbrock H, Daniels K, Cotton D, Roy D, Pollentier S, Sand M. PMID: 33354862; PMCID: PMC8451588.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    113. Impaired Potentiation of Theta Oscillations During a Visual Cortical Plasticity Paradigm in Individuals With Schizophrenia. Front Psychiatry. 2020; 11:590567. Hamilton HK, Roach BJ, Cavus I, Teyler TJ, Clapp WC, Ford JM, Tarakci E, Krystal JH, Mathalon DH. PMID: 33391054; PMCID: PMC7772351.
      View in: PubMed   Mentions: 13  
    114. Reconciling competing mechanisms posited to underlie auditory verbal hallucinations. Philos Trans R Soc Lond B Biol Sci. 2021 02; 376(1817):20190702. Thakkar KN, Mathalon DH, Ford JM. PMID: 33308062; PMCID: PMC7741078.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    115. Reward processing electrophysiology in schizophrenia: Effects of age and illness phase. Neuroimage Clin. 2020; 28:102492. Abram SV, Roach BJ, Holroyd CB, Paulus MP, Ford JM, Mathalon DH, Fryer SL. PMID: 33395983; PMCID: PMC7695886.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    116. Challenges Associated With Neuropharmacological Challenge Studies. Biol Psychiatry. 2020 11 01; 88(9):670-672. Mathalon DH. PMID: 33032692.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    117. Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome. Schizophr Res. 2021 01; 227:44-51. Carrión RE, Auther AM, McLaughlin D, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman L, Stone W, Tsuang M, Walker EF, Woods SW, Torous J, Cornblatt BA. PMID: 33131983.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    118. Depression: An actionable outcome for those at clinical high-risk. Schizophr Res. 2021 01; 227:38-43. Addington J, Farris MS, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Stone WS, Keshevan M, Woods SW. PMID: 33129638; PMCID: PMC7854482.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    119. Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 02; 6(2):178-187. Hamilton HK, Roach BJ, Mathalon DH. PMID: 33431345; PMCID: PMC8128162.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    120. Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study. Clin Neurophysiol. 2020 12; 131(12):2899-2909. Roach BJ, Carrión RE, Hamilton HK, Bachman P, Belger A, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, S Cadenhead K, Cannon TD, A Cornblatt B, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Mathalon DH. PMID: 33160266; PMCID: PMC8323616.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    121. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis. Schizophr Res. 2021 01; 227:95-100. Worthington MA, Walker EF, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD. PMID: 33046334; PMCID: PMC8287972.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    122. A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants. Neuropsychopharmacology. 2021 01; 46(2):478-485. Abdallah CG, Ahn KH, Averill LA, Nemati S, Averill CL, Fouda S, Ranganathan M, Morgan PT, D'Souza DC, Mathalon DH, Krystal JH, Driesen NR. PMID: 32967000; PMCID: PMC7852889.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    123. Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis. Schizophr Res. 2021 01; 227:72-77. Calkins ME, Woods SW, Bearden CE, Liu L, Moore TM, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Mathalon DH, Keshavan M, Stone WS, Addington J. PMID: 32943313.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    124. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm. Front Psychiatry. 2020; 11:833. Cadenhead KS, Duncan E, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bauchman P, Belger A, Carrión RE, Donkers F, Johannesen J, Light G, Niznikiewicz M, Nunag J, Roach B. PMID: 33005152; PMCID: PMC7479820.
      View in: PubMed   Mentions: 3  
    125. Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms. Early Interv Psychiatry. 2021 08; 15(4):818-827. LoPilato AM, Zhang Y, Pike M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 32770658.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    126. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. J Abnorm Psychol. 2020 Aug; 129(6):599-611. Fryer SL, Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Mathalon DH. PMID: 32757603; PMCID: PMC7430496.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    127. Effects of Transcranial Direct Current Stimulation on Visual Neuroplasticity in Schizophrenia. Clin EEG Neurosci. 2020 Nov; 51(6):382-389. Jahshan C, Wynn JK, Roach BJ, Mathalon DH, Green MF. PMID: 32463701.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    128. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit. Schizophr Res. 2021 01; 227:10-17. Woods SW, Bearden CE, Sabb FW, Stone WS, Torous J, Cornblatt BA, Perkins DO, Cadenhead KS, Addington J, Powers AR, Mathalon DH, Calkins ME, Wolf DH, Corcoran CM, Horton LE, Mittal VA, Schiffman J, Ellman LM, Strauss GP, Mamah D, Choi J, Pearlson GD, Shah JL, Fusar-Poli P, Arango C, Perez J, Koutsouleris N, Wang J, Kwon JS, Walsh BC, McGlashan TH, Hyman SE, Gur RE, Cannon TD, Kane JM, Anticevic A. PMID: 32402605; PMCID: PMC8218020.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    129. A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology. Neuropsychopharmacology. 2020 08; 45(9):1411-1422. Javitt DC, Siegel SJ, Spencer KM, Mathalon DH, Hong LE, Martinez A, Ehlers CL, Abbas AI, Teichert T, Lakatos P, Womelsdorf T. PMID: 32375159; PMCID: PMC7360555.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    130. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study. Schizophr Res. 2021 01; 227:28-37. Devoe DJ, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. PMID: 32362460; PMCID: PMC7606256.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    131. Pathways from performance monitoring to negative symptoms and functional outcomes in psychotic disorders. Psychol Med. 2021 09; 51(12):2012-2022. Foti D, Perlman G, Bromet EJ, Harvey PD, Hajcak G, Mathalon DH, Kotov R. PMID: 32317045; PMCID: PMC10769507.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    132. North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description. Schizophr Res. 2022 05; 243:262-267. Addington J, Liu L, Brummitt K, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 32317224; PMCID: PMC7572535.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    133. Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis. Biol Psychiatry. 2020 08 15; 88(4):294-303. Hamilton HK, Boos AK, Mathalon DH. PMID: 32507388; PMCID: PMC8300573.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    134. Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial. Schizophr Bull. 2020 04 10; 46(3):661-669. Abram SV, De Coster L, Roach BJ, Mueller BA, van Erp TGM, Calhoun VD, Preda A, Lim KO, Turner JA, Ford JM, Mathalon DH, Woolley JD. PMID: 31595302; PMCID: PMC7147578.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    135. Stability of mismatch negativity event-related potentials in a multisite study. Int J Methods Psychiatr Res. 2020 06; 29(2):e1819. Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Kenney JG, Light G, Niznikiewicz M, Addington J, Bearden CE, Owens EM, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman L, Tsuang M, Walker EF, Woods SW, Mathalon DH. PMID: 32232944; PMCID: PMC7301288.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    136. Covarying structural alterations in laterality of the temporal lobe in schizophrenia: A case for source-based laterality. NMR Biomed. 2020 06; 33(6):e4294. DeRamus TP, Silva RF, Iraji A, Damaraju E, Belger A, Ford JM, McEwen SC, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD. PMID: 32207187; PMCID: PMC8311554.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    137. The genetic architecture of the human cerebral cortex. Science. 2020 03 20; 367(6484). Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, Lind PA, Pizzagalli F, Ching CRK, McMahon MAB, Shatokhina N, Zsembik LCP, Thomopoulos SI, Zhu AH, Strike LT, Agartz I, Alhusaini S, Almeida MAA, Alnæs D, Amlien IK, Andersson M, Ard T, Armstrong NJ, Ashley-Koch A, Atkins JR, Bernard M, Brouwer RM, Buimer EEL, Bülow R, Bürger C, Cannon DM, Chakravarty M, Chen Q, Cheung JW, Couvy-Duchesne B, Dale AM, Dalvie S, de Araujo TK, de Zubicaray GI, de Zwarte SMC, den Braber A, Doan NT, Dohm K, Ehrlich S, Engelbrecht HR, Erk S, Fan CC, Fedko IO, Foley SF, Ford JM, Fukunaga M, Garrett ME, Ge T, Giddaluru S, Goldman AL, Green MJ, Groenewold NA, Grotegerd D, Gurholt TP, Gutman BA, Hansell NK, Harris MA, Harrison MB, Haswell CC, Hauser M, Herms S, Heslenfeld DJ, Ho NF, Hoehn D, Hoffmann P, Holleran L, Hoogman M, Hottenga JJ, Ikeda M, Janowitz D, Jansen IE, Jia T, Jockwitz C, Kanai R, Karama S, Kasperaviciute D, Kaufmann T, Kelly S, Kikuchi M, Klein M, Knapp M, Knodt AR, Krämer B, Lam M, Lancaster TM, Lee PH, Lett TA, Lewis LB, Lopes-Cendes I, Luciano M, Macciardi F, Marquand AF, Mathias SR, Melzer TR, Milaneschi Y, Mirza-Schreiber N, Moreira JCV, Mühleisen TW, Müller-Myhsok B, Najt P, Nakahara S, Nho K, Olde Loohuis LM, Orfanos DP, Pearson JF, Pitcher TL, Pütz B, Quidé Y, Ragothaman A, Rashid FM, Reay WR, Redlich R, Reinbold CS, Repple J, Richard G, Riedel BC, Risacher SL, Rocha CS, Mota NR, Salminen L, Saremi A, Saykin AJ, Schlag F, Schmaal L, Schofield PR, Secolin R, Shapland CY, Shen L, Shin J, Shumskaya E, Sønderby IE, Sprooten E, Tansey KE, Teumer A, Thalamuthu A, Tordesillas-Gutiérrez D, Turner JA, Uhlmann A, Vallerga CL, van der Meer D, van Donkelaar MMJ, van Eijk L, van Erp TGM, van Haren NEM, van Rooij D, van Tol MJ, Veldink JH, Verhoef E, Walton E, Wang M, Wang Y, Wardlaw JM, Wen W, Westlye LT, Whelan CD, Witt SH, Wittfeld K, Wolf C, Wolfers T, Wu JQ, Yasuda CL, Zaremba D, Zhang Z, Zwiers MP, Artiges E, Assareh AA, Ayesa-Arriola R, Belger A, Brandt CL, Brown GG, Cichon S, Curran JE, Davies GE, Degenhardt F, Dennis MF, Dietsche B, Djurovic S, Doherty CP, Espiritu R, Garijo D, Gil Y, Gowland PA, Green RC, Häusler AN, Heindel W, Ho BC, Hoffmann WU, Holsboer F, Homuth G, Hosten N, Jack CR, Jang M, Jansen A, Kimbrel NA, Kolskår K, Koops S, Krug A, Lim KO, Luykx JJ, Mathalon DH, Mather KA, Mattay VS, Matthews S, Mayoral Van Son J, McEwen SC, Melle I, Morris DW, Mueller BA, Nauck M, Nordvik JE, Nöthen MM, O'Leary DS, Opel N, Martinot MP, Pike GB, Preda A, Quinlan EB, Rasser PE, Ratnakar V, Reppermund S, Steen VM, Tooney PA, Torres FR, Veltman DJ, Voyvodic JT, Whelan R, White T, Yamamori H, Adams HHH, Bis JC, Debette S, Decarli C, Fornage M, Gudnason V, Hofer E, Ikram MA, Launer L, Longstreth WT, Lopez OL, Mazoyer B, Mosley TH, Roshchupkin GV, Satizabal CL, Schmidt R, Seshadri S, Yang Q, Alzheimer’s Disease Neuroimaging Initiative, CHARGE Consortium, EPIGEN Consortium, IMAGEN Consortium, SYS Consortium, Parkinson’s Progression Markers Initiative, Alvim MKM, Ames D, Anderson TJ, Andreassen OA, Arias-Vasquez A, Bastin ME, Baune BT, Beckham JC, Blangero J, Boomsma DI, Brodaty H, Brunner HG, Buckner RL, Buitelaar JK, Bustillo JR, Cahn W, Cairns MJ, Calhoun V, Carr VJ, Caseras X, Caspers S, Cavalleri GL, Cendes F, Corvin A, Crespo-Facorro B, Dalrymple-Alford JC, Dannlowski U, de Geus EJC, Deary IJ, Delanty N, Depondt C, Desrivières S, Donohoe G, Espeseth T, Fernández G, Fisher SE, Flor H, Forstner AJ, Francks C, Franke B, et al. PMID: 32193296; PMCID: PMC7295264.
      View in: PubMed   Mentions: 237     Fields:    Translation:Humans
    138. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort. Psychoneuroendocrinology. 2020 05; 115:104649. Cullen AE, Addington J, Bearden CE, Stone WS, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 32197198; PMCID: PMC7193890.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    139. Stress perception following childhood adversity: Unique associations with adversity type and sex. Dev Psychopathol. 2020 02; 32(1):343-356. LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 30846020.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    140. Increased global cognition correlates with increased thalamo-temporal connectivity in response to targeted cognitive training for recent onset schizophrenia. Schizophr Res. 2020 04; 218:131-137. Ramsay IS, Roach BJ, Fryer S, Fisher M, Loewy R, Ford JM, Vinogradov S, Mathalon DH. PMID: 32007346; PMCID: PMC7299776.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    141. Weighted average of shared trajectory: A new estimator for dynamic functional connectivity efficiently estimates both rapid and slow changes over time. J Neurosci Methods. 2020 Jan 21; 334:108600. Faghiri A, Iraji A, Damaraju E, Belger A, Ford J, Mathalon D, Mcewen S, Mueller B, Pearlson G, Preda A, Turner J, Vaidya JG, Van Erp TGM, Calhoun VD. PMID: 31978489; PMCID: PMC7371494.
      View in: PubMed   Mentions: 8     Fields:    
    142. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator. Early Interv Psychiatry. 2021 02; 15(1):96-103. Worthington MA, Miklowitz DJ, O'Brien M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 31943807; PMCID: PMC7358123.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    143. Meta-Modal Information Flow: A Method for Capturing Multimodal Modular Disconnectivity in Schizophrenia. IEEE Trans Biomed Eng. 2020 09; 67(9):2572-2584. Falakshahi H, Vergara VM, Liu J, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Rokham H, Sui J, Turner JA, Plis S, Calhoun VD. PMID: 31944934; PMCID: PMC7538162.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    144. The prodromal phase: Time to broaden the scope beyond transition to psychosis? Schizophr Res. 2020 02; 216:5-6. Ferrarelli F, Mathalon D. PMID: 31924373; PMCID: PMC7239711.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    145. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis. Schizophr Res. 2020 02; 216:184-191. Yoviene Sykes LA, Ferrara M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woodberry KA, Powers AR, Ponce AN, Cahill JD, Pollard JM, Srihari VH, Woods SW. PMID: 31864837; PMCID: PMC7239715.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    146. Duration of the psychosis prodrome. Schizophr Res. 2020 02; 216:443-449. Powers AR, Addington J, Perkins DO, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH, Woods SW. PMID: 31806523; PMCID: PMC7539292.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    147. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. Am J Psychiatry. 2020 02 01; 177(2):155-163. Perkins DO, Olde Loohuis L, Barbee J, Ford J, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW. PMID: 31711302; PMCID: PMC7202227.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    148. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. JAMA Psychiatry. 2019 11 01; 76(11):1187-1197. Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrion RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD, Mathalon DH. PMID: 31389974; PMCID: PMC6686970.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    149. Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300. Schizophr Bull. 2019 09 11; 45(5):1068-1080. Hamilton HK, Woods SW, Roach BJ, Llerena K, McGlashan TH, Srihari VH, Ford JM, Mathalon DH. PMID: 30753731; PMCID: PMC6737543.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    150. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. Am J Psychiatry. 2020 02 01; 177(2):164-171. Allswede DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan T, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. PMID: 31509005; PMCID: PMC7002249.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    151. Efference Copy, Corollary Discharge, Predictive Coding, and Psychosis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 09; 4(9):764-767. Ford JM, Mathalon DH. PMID: 31495399.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    152. Evaluating visual neuroplasticity with EEG in schizophrenia outpatients. Schizophr Res. 2019 10; 212:40-46. Wynn JK, Roach BJ, McCleery A, Marder SR, Mathalon DH, Green MF. PMID: 31434625; PMCID: PMC6791734.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    153. Oxytocin increases eye gaze in schizophrenia. Schizophr Res. 2019 10; 212:177-185. Bradley ER, Seitz A, Niles AN, Rankin KP, Mathalon DH, O'Donovan A, Woolley JD. PMID: 31416746; PMCID: PMC6791758.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    154. Sleep problems and attenuated psychotic symptoms in youth at clinical high-risk for psychosis. Psychiatry Res. 2019 12; 282:112492. Goines KB, LoPilato AM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 31387769; PMCID: PMC6888892.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    155. Altered Domain Functional Network Connectivity Strength and Randomness in Schizophrenia. Front Psychiatry. 2019; 10:499. Vergara VM, Damaraju E, Turner JA, Pearlson G, Belger A, Mathalon DH, Potkin SG, Preda A, Vaidya JG, van Erp TGM, McEwen S, Calhoun VD. PMID: 31396111; PMCID: PMC6664085.
      View in: PubMed   Mentions: 3  
    156. Aberrant activity in conceptual networks underlies N400 deficits and unusual thoughts in schizophrenia. Neuroimage Clin. 2019; 24:101960. Jacob MS, Ford JM, Roach BJ, Calhoun VD, Mathalon DH. PMID: 31398555; PMCID: PMC6699247.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    157. Characterizing Whole Brain Temporal Variation of Functional Connectivity via Zero and First Order Derivatives of Sliding Window Correlations. Front Neurosci. 2019; 13:634. Espinoza FA, Vergara VM, Damaraju E, Henke KG, Faghiri A, Turner JA, Belger AA, Ford JM, McEwen SC, Mathalon DH, Mueller BA, Potkin SG, Preda A, Vaidya JG, van Erp TGM, Calhoun VD. PMID: 31316333; PMCID: PMC6611425.
      View in: PubMed   Mentions: 7  
    158. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophr Bull. 2019 06 18; 45(4):763-772. Carrión RE, Auther AM, McLaughlin D, Olsen R, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cornblatt BA. PMID: 30351423; PMCID: PMC6581127.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    159. Salience-Default Mode Functional Network Connectivity Linked to Positive and Negative Symptoms of Schizophrenia. Schizophr Bull. 2019 06 18; 45(4):892-901. Hare SM, Ford JM, Mathalon DH, Damaraju E, Bustillo J, Belger A, Lee HJ, Mueller BA, Lim KO, Brown GG, Preda A, van Erp TGM, Potkin SG, Calhoun VD, Turner JA. PMID: 30169884; PMCID: PMC6581131.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    160. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. Schizophr Bull. 2019 06 18; 45(4):924-933. Cao H, McEwen SC, Chung Y, Chén OY, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 30215784; PMCID: PMC6581134.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    161. Test-retest reliability of time-frequency measures of auditory steady-state responses in patients with schizophrenia and healthy controls. Neuroimage Clin. 2019; 23:101878. Roach BJ, D'Souza DC, Ford JM, Mathalon DH. PMID: 31228795; PMCID: PMC6587022.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    162. Dentate gyrus volume deficit in schizophrenia. Psychol Med. 2020 06; 50(8):1267-1277. Nakahara S, Turner JA, Calhoun VD, Lim KO, Mueller B, Bustillo JR, O'Leary DS, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Macciardi F, Matsumoto M, Potkin SG, van Erp TGM. PMID: 31155012; PMCID: PMC7068799.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    163. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. Neuroimage Clin. 2019; 23:101862. Chung Y, Allswede D, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, North American Prodrome Longitudinal Study (NAPLS) Consortium. PMID: 31150956; PMCID: PMC6541907.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    164. Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial. Neuropsychopharmacology. 2019 10; 44(11):1925-1931. De Coster L, Lin L, Mathalon DH, Woolley JD. PMID: 31103018; PMCID: PMC6785003.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    165. Parallel group ICA+ICA: Joint estimation of linked functional network variability and structural covariation with application to schizophrenia. Hum Brain Mapp. 2019 09; 40(13):3795-3809. Qi S, Sui J, Chen J, Liu J, Jiang R, Silva R, Iraji A, Damaraju E, Salman M, Lin D, Fu Z, Zhi D, Turner JA, Bustillo J, Ford JM, Mathalon DH, Voyvodic J, McEwen S, Preda A, Belger A, Potkin SG, Mueller BA, Adali T, Calhoun VD. PMID: 31099151; PMCID: PMC6865807.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    166. Autoconnectivity: A new perspective on human brain function. J Neurosci Methods. 2019 07 15; 323:68-76. Arbabshirani MR, Preda A, Vaidya JG, Potkin SG, Pearlson G, Voyvodic J, Mathalon D, van Erp T, Michael A, Kiehl KA, Turner JA, Calhoun VD. PMID: 31005575.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    167. N-BiC: A Method for Multi-Component and Symptom Biclustering of Structural MRI Data: Application to Schizophrenia. IEEE Trans Biomed Eng. 2020 01; 67(1):110-121. Rahaman MA, Turner JA, Gupta CN, Rachakonda S, Chen J, Liu J, van Erp TGM, Potkin S, Ford J, Mathalon D, Lee HJ, Jiang W, Mueller BA, Andreassen O, Agartz I, Sponheim SR, Mayer AR, Stephen J, Jung RE, Canive J, Bustillo J, Calhoun VD. PMID: 30946659; PMCID: PMC7906485.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    168. A method for building a genome-connectome bipartite graph model. J Neurosci Methods. 2019 05 15; 320:64-71. Yu Q, Chen J, Du Y, Sui J, Damaraju E, Turner JA, van Erp TGM, Macciardi F, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Preda A, Vaidya J, Pearlson GD, Calhoun VD. PMID: 30902651; PMCID: PMC6504548.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    169. The spatial chronnectome reveals a dynamic interplay between functional segregation and integration. Hum Brain Mapp. 2019 07; 40(10):3058-3077. Iraji A, Deramus TP, Lewis N, Yaesoubi M, Stephen JM, Erhardt E, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD. PMID: 30884018; PMCID: PMC6548674.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    170. Group ICA for identifying biomarkers in schizophrenia: 'Adaptive' networks via spatially constrained ICA show more sensitivity to group differences than spatio-temporal regression. Neuroimage Clin. 2019; 22:101747. Salman MS, Du Y, Lin D, Fu Z, Fedorov A, Damaraju E, Sui J, Chen J, Mayer AR, Posse S, Mathalon DH, Ford JM, Van Erp T, Calhoun VD. PMID: 30921608; PMCID: PMC6438914.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    171. Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI-Based Brain Graphs Across Sites, Sessions, and Paradigms. Cereb Cortex. 2019 03 01; 29(3):1263-1279. Cao H, McEwen SC, Forsyth JK, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 29522112; PMCID: PMC6676966.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    172. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services. J Am Acad Child Adolesc Psychiatry. 2019 06; 58(6):582-588. Foss-Feig JH, Velthorst E, Smith L, Reichenberg A, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Keshavan M, Tsuang MT, Walker EF, Woods SW, Cannon TD, Bearden CE. PMID: 30797038; PMCID: PMC7781438.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    173. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study. Schizophr Res. 2019 06; 208:41-43. Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, North American Prodrome Longitudinal Study Consortium. PMID: 30745066.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    174. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophr Res. 2019 11; 213:48-55. LoPilato AM, Goines K, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. PMID: 30745068.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    175. Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophr Res. 2020 12; 226:30-37. Cao H, Chung Y, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión R, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 30704864; PMCID: PMC8376298.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    176. Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm. Psychol Med. 2019 05; 49(7):1195-1206. McCleery A, Mathalon DH, Wynn JK, Roach BJ, Hellemann GS, Marder SR, Green MF. PMID: 30642411; PMCID: PMC6499668.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    177. Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for Psychosis. Schizophr Bull. 2019 01 01; 45(1):158-168. Fryer SL, Roach BJ, Ford JM, Donaldson KR, Calhoun VD, Pearlson GD, Kiehl KA, Srihari VH, McGlashan TH, Woods SW, Mathalon DH. PMID: 29385625; PMCID: PMC6293268.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    178. Efference copy/corollary discharge function and targeted cognitive training in patients with schizophrenia. Int J Psychophysiol. 2019 11; 145:91-98. Roach BJ, Ford JM, Biagianti B, Hamilton HK, Ramsay IS, Fisher M, Loewy R, Vinogradov S, Mathalon DH. PMID: 30599145; PMCID: PMC6616012.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    179. Spatial dynamics within and between brain functional domains: A hierarchical approach to study time-varying brain function. Hum Brain Mapp. 2019 04 15; 40(6):1969-1986. Iraji A, Fu Z, Damaraju E, DeRamus TP, Lewis N, Bustillo JR, Lenroot RK, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD. PMID: 30588687; PMCID: PMC6692083.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    180. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behav Immun. 2019 02; 76:268-274. Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Woods SW, Walker EF, Perkins DO. PMID: 30496778; PMCID: PMC6348114.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    181. Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process? Biol Psychiatry. 2019 04 01; 85(7):e35-e39. van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Clark VP, Mueller BA, de Zwarte SMC, Ophoff RA, van Haren NEM, Andreassen OA, Gurholt TP, Gruber O, Kraemer B, Richter A, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Catts S, Fullerton JM, Green MJ, Henskens F, Jablensky A, Mowry BJ, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Hong E, Kochunov P, Gur RE, Gur RC, Ford JM, Macciardi F, Mathalon DH, Potkin SG, Preda A, Fan F, Ehrlich S, King MD, De Haan L, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, Pomarol-Clotet E, Kelly S, Ciufolini S, Radua J, Murray R, Marques TR, Simmons A, Borgwardt S, Schönborn-Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Yun JY, Cannon DM, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L, Karolinska Schizophrenia Project, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, McIntosh AM, Whalley HC, Knöchel C, Oertel-Knöchel V, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA. PMID: 30470561; PMCID: PMC7041557.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    182. Effects of conflict and strategic processing on neural responses to errors in schizophrenia. Biol Psychol. 2019 01; 140:9-18. Donaldson KR, Roach BJ, Ford JM, Lai K, Sreenivasan KK, Mathalon DH. PMID: 30428312.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    183. Tobacco use and psychosis risk in persons at clinical high risk. Early Interv Psychiatry. 2019 10; 13(5):1173-1181. Ward HB, Lawson MT, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Jeffries CD, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Perkins DO. PMID: 30362261.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    184. Deficits in Cortical Suppression During Vocalization are Associated With Structural Abnormalities in the Arcuate Fasciculus in Early Illness Schizophrenia and Clinical High Risk for Psychosis. Schizophr Bull. 2018 10 17; 44(6):1312-1322. Whitford TJ, Oestreich LKL, Ford JM, Roach BJ, Loewy RL, Stuart BK, Mathalon DH. PMID: 29194516; PMCID: PMC6192501.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    185. A framework for linking resting-state chronnectome/genome features in schizophrenia: A pilot study. Neuroimage. 2019 01 01; 184:843-854. Rashid B, Chen J, Rashid I, Damaraju E, Liu J, Miller R, Agcaoglu O, van Erp TGM, Lim KO, Turner JA, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Bustillo JR, Pearlson GD, Calhoun VD. PMID: 30300752; PMCID: PMC6230505.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    186. Digital Trajectories to Care in First-Episode Psychosis. Psychiatr Serv. 2018 12 01; 69(12):1259-1263. Birnbaum ML, Rizvi AF, Faber K, Addington J, Correll CU, Gerber C, Lahti AC, Loewy RL, Mathalon DH, Nelson LA, Voineskos AN, Walker EF, Ward E, Kane JM. PMID: 30256181; PMCID: PMC6408281.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    187. Deficient auditory predictive coding during vocalization in the psychosis risk syndrome and in early illness schizophrenia: the final expanded sample. Psychol Med. 2019 08; 49(11):1897-1904. Mathalon DH, Roach BJ, Ferri JM, Loewy RL, Stuart BK, Perez VB, Trujillo TH, Ford JM. PMID: 30249315.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    188. Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium. Schizophr Res. 2019 02; 204:96-103. Cadenhead KS, Minichino A, Kelsven S, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Yao J, North American Prodromal Longitudinal Studies (NAPLS) consortium. PMID: 30249470; PMCID: PMC6402991.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    189. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nat Commun. 2018 09 21; 9(1):3836. Cao H, Chén OY, Chung Y, Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Anticevic A, Woods SW, Cannon TD. PMID: 30242220; PMCID: PMC6155100.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    190. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychol Med. 2019 07; 49(10):1670-1677. Addington J, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Santesteban-Echarri O, Woods SW. PMID: 30176955.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    191. Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis. Schizophr Res. 2019 02; 204:334-336. Shakeel MK, Lu L, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, Addington J. PMID: 30181061; PMCID: PMC6395507.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    192. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk. JAMA Psychiatry. 2018 09 01; 75(9):960-968. Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, North American Prodrome Longitudinal Study (NAPLS) Consortium and the Pediatric Imaging, Neurocognit. PMID: 29971330; PMCID: PMC6142910.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    193. Gamma Band Phase Delay in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 02; 4(2):131-139. Roach BJ, Ford JM, Mathalon DH. PMID: 30314905.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    194. Multimodal neuromarkers in schizophrenia via cognition-guided MRI fusion. Nat Commun. 2018 08 02; 9(1):3028. Sui J, Qi S, van Erp TGM, Bustillo J, Jiang R, Lin D, Turner JA, Damaraju E, Mayer AR, Cui Y, Fu Z, Du Y, Chen J, Potkin SG, Preda A, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen SC, O'Leary DS, McMahon A, Jiang T, Calhoun VD. PMID: 30072715; PMCID: PMC6072778.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    195. Transient Patterns of Functional Dysconnectivity in Clinical High Risk and Early Illness Schizophrenia Individuals Compared with Healthy Controls. Brain Connect. 2019 02; 9(1):60-76. Mennigen E, Fryer SL, Rashid B, Damaraju E, Du Y, Loewy RL, Stuart BK, Calhoun VD, Mathalon DH. PMID: 29855202; PMCID: PMC6390658.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    196. The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis. Stress Health. 2018 Dec; 34(5):591-600. Hampton JN, Trotman HD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, Walker EF. PMID: 29956456; PMCID: PMC6289596.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    197. A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS. Schizophr Res. 2018 11; 201:113-119. Preda A, Nguyen DD, Bustillo JR, Belger A, O'Leary DS, McEwen S, Ling S, Faziola L, Mathalon DH, Ford JM, Potkin SG, FBIRN, van Erp TGM. PMID: 29935887; PMCID: PMC7039318.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    198. Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia. Schizophr Res. 2018 11; 201:393-399. Nakahara S, Medland S, Turner JA, Calhoun VD, Lim KO, Mueller BA, Bustillo JR, O'Leary DS, Vaidya JG, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Guffanti G, Macciardi F, Potkin SG, van Erp TGM. PMID: 29907492; PMCID: PMC6252137.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    199. Reduced higher-dimensional resting state fMRI dynamism in clinical high-risk individuals for schizophrenia identified by meta-state analysis. Schizophr Res. 2018 11; 201:217-223. Mennigen E, Miller RL, Rashid B, Fryer SL, Loewy RL, Stuart BK, Mathalon DH, Calhoun VD. PMID: 29907493; PMCID: PMC6252113.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    200. Networks of blood proteins in the neuroimmunology of schizophrenia. Transl Psychiatry. 2018 06 06; 8(1):112. Jeffries CD, Perkins DO, Fournier M, Do KQ, Cuenod M, Khadimallah I, Domenici E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, Woods SW. PMID: 29875399; PMCID: PMC5990539.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    201. Decreased hemispheric connectivity and decreased intra- and inter- hemisphere asymmetry of resting state functional network connectivity in schizophrenia. Brain Imaging Behav. 2018 Jun; 12(3):615-630. Agcaoglu O, Miller R, Damaraju E, Rashid B, Bustillo J, Cetin MS, Van Erp TGM, McEwen S, Preda A, Ford JM, Lim KO, Manoach DS, Mathalon DH, Potkin SG, Calhoun VD. PMID: 28434159; PMCID: PMC5651208.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    202. Childhood trauma and clinical high risk for psychosis. Schizophr Res. 2019 03; 205:10-14. Loewy RL, Corey S, Amirfathi F, Dabit S, Fulford D, Pearson R, Hua JPY, Schlosser D, Stuart BK, Mathalon DH, Vinogradov S. PMID: 29779964; PMCID: PMC6939986.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    203. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biol Psychiatry. 2018 11 01; 84(9):644-654. van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, Mueller BA, Cahn W, de Zwarte SMC, Hulshoff Pol HE, Kahn RS, Ophoff RA, van Haren NEM, Andreassen OA, Dale AM, Doan NT, Gurholt TP, Hartberg CB, Haukvik UK, Jørgensen KN, Lagerberg TV, Melle I, Westlye LT, Gruber O, Kraemer B, Richter A, Zilles D, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Carr VJ, Catts S, Cropley VL, Fullerton JM, Green MJ, Henskens FA, Jablensky A, Lenroot RK, Mowry BJ, Michie PT, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Morris DW, Hong E, Kochunov P, Beard LM, Gur RE, Gur RC, Satterthwaite TD, Wolf DH, Belger A, Brown GG, Ford JM, Macciardi F, Mathalon DH, O'Leary DS, Potkin SG, Preda A, Voyvodic J, Lim KO, McEwen S, Yang F, Tan Y, Tan S, Wang Z, Fan F, Chen J, Xiang H, Tang S, Guo H, Wan P, Wei D, Bockholt HJ, Ehrlich S, Wolthusen RPF, King MD, Shoemaker JM, Sponheim SR, De Haan L, Koenders L, Machielsen MW, van Amelsvoort T, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, McKenna PJ, Pomarol-Clotet E, Salvador R, Corvin A, Donohoe G, Kelly S, Whelan CD, Dickie EW, Rotenberg D, Voineskos AN, Ciufolini S, Radua J, Dazzan P, Murray R, Reis Marques T, Simmons A, Borgwardt S, Egloff L, Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Wang L, Jönsson EG, Koops S, Sommer IEC, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Stephen JM, Kwon JS, Yun JY, Cannon DM, McDonald C, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L, Karolinska Schizophrenia Project, Busatto GF, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, Hagenaars SP, McIntosh AM, Whalley HC, Lawrie SM, Knöchel C, Oertel-Knöchel V, Stäblein M, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, McMahon A, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA. PMID: 29960671; PMCID: PMC6177304.
      View in: PubMed   Mentions: 301     Fields:    Translation:Humans
    204. Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study. Schizophr Res. 2018 11; 201:130-136. Davidson CA, Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW, Johannesen JK. PMID: 29751984; PMCID: PMC8130825.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    205. Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia. Schizophr Bull. 2018 04 06; 44(3):492-504. Hamilton HK, Perez VB, Ford JM, Roach BJ, Jaeger J, Mathalon DH. PMID: 29036701; PMCID: PMC5890465.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    206. Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia. Schizophr Res. 2018 09; 199:226-234. Hare SM, Law AS, Ford JM, Mathalon DH, Ahmadi A, Damaraju E, Bustillo J, Belger A, Lee HJ, Mueller BA, Lim KO, Brown GG, Preda A, van Erp TGM, Potkin SG, Calhoun VD, Turner JA. PMID: 29571753; PMCID: PMC6148405.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    207. Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms. Psychol Med. 2018 11; 48(15):2492-2499. Ferri J, Ford JM, Roach BJ, Turner JA, van Erp TG, Voyvodic J, Preda A, Belger A, Bustillo J, O'Leary D, Mueller BA, Lim KO, McEwen SC, Calhoun VD, Diaz M, Glover G, Greve D, Wible CG, Vaidya JG, Potkin SG, Mathalon DH. PMID: 29444726.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    208. Hallucinations, neuroplasticity, and prediction errors in schizophrenia. Scand J Psychol. 2018 02; 59(1):41-48. McCleery A, Wynn JK, Mathalon DH, Green MF. PMID: 29356009; PMCID: PMC5969574.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    209. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome. Schizophr Res. 2018 07; 197:522-530. Ryan AT, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD, Walker EF. PMID: 29279247; PMCID: PMC6015526.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    210. Blunted amygdala activity is associated with depression severity in treatment-resistant depression. Cogn Affect Behav Neurosci. 2017 12; 17(6):1221-1231. Ferri J, Eisendrath SJ, Fryer SL, Gillung E, Roach BJ, Mathalon DH. PMID: 29063521; PMCID: PMC5728990.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    211. Reliability of functional magnetic resonance imaging activation during working memory in a multisite study: Clarification and implications for statistical power. Neuroimage. 2017 12; 163:456-458. Cannon TD, Cao H, Mathalon DH, Forsyth J, NAPLS consortium. PMID: 29113944; PMCID: PMC5716858.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    212. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study: Clarification and implications for statistical power. Hum Brain Mapp. 2018 01; 39(1):599-601. Cannon TD, Cao H, Mathalon DH, Gee DG, NAPLS consortium. PMID: 29086463; PMCID: PMC5718980.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    213. Identifying functional network changing patterns in individuals at clinical high-risk for psychosis and patients with early illness schizophrenia: A group ICA study. Neuroimage Clin. 2018; 17:335-346. Du Y, Fryer SL, Lin D, Sui J, Yu Q, Chen J, Stuart B, Loewy RL, Calhoun VD, Mathalon DH. PMID: 29159045; PMCID: PMC5681342.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    214. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry. 2018 05; 23(5):1261-1269. Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, Calhoun V, Cannon D, Carr V, Catts S, Chen J, Chen JX, Chen X, Chiapponi C, Cho KK, Ciullo V, Corvin AS, Crespo-Facorro B, Cropley V, De Rossi P, Diaz-Caneja CM, Dickie EW, Ehrlich S, Fan FM, Faskowitz J, Fatouros-Bergman H, Flyckt L, Ford JM, Fouche JP, Fukunaga M, Gill M, Glahn DC, Gollub R, Goudzwaard ED, Guo H, Gur RE, Gur RC, Gurholt TP, Hashimoto R, Hatton SN, Henskens FA, Hibar DP, Hickie IB, Hong LE, Horacek J, Howells FM, Hulshoff Pol HE, Hyde CL, Isaev D, Jablensky A, Jansen PR, Janssen J, Jönsson EG, Jung LA, Kahn RS, Kikinis Z, Liu K, Klauser P, Knöchel C, Kubicki M, Lagopoulos J, Langen C, Lawrie S, Lenroot RK, Lim KO, Lopez-Jaramillo C, Lyall A, Magnotta V, Mandl RCW, Mathalon DH, McCarley RW, McCarthy-Jones S, McDonald C, McEwen S, McIntosh A, Melicher T, Mesholam-Gately RI, Michie PT, Mowry B, Mueller BA, Newell DT, O'Donnell P, Oertel-Knöchel V, Oestreich L, Paciga SA, Pantelis C, Pasternak O, Pearlson G, Pellicano GR, Pereira A, Pineda Zapata J, Piras F, Potkin SG, Preda A, Rasser PE, Roalf DR, Roiz R, Roos A, Rotenberg D, Satterthwaite TD, Savadjiev P, Schall U, Scott RJ, Seal ML, Seidman LJ, Shannon Weickert C, Whelan CD, Shenton ME, Kwon JS, Spalletta G, Spaniel F, Sprooten E, Stäblein M, Stein DJ, Sundram S, Tan Y, Tan S, Tang S, Temmingh HS, Westlye LT, Tønnesen S, Tordesillas-Gutierrez D, Doan NT, Vaidya J, van Haren NEM, Vargas CD, Vecchio D, Velakoulis D, Voineskos A, Voyvodic JQ, Wang Z, Wan P, Wei D, Weickert TW, Whalley H, White T, Whitford TJ, Wojcik JD, Xiang H, Xie Z, Yamamori H, Yang F, Yao N, Zhang G, Zhao J, van Erp TGM, Turner J, Thompson PM, Donohoe G. PMID: 29038599; PMCID: PMC5984078.
      View in: PubMed   Mentions: 277     Fields:    Translation:Humans
    215. Dynamic functional connectivity impairments in early schizophrenia and clinical high-risk for psychosis. Neuroimage. 2018 10 15; 180(Pt B):632-645. Du Y, Fryer SL, Fu Z, Lin D, Sui J, Chen J, Damaraju E, Mennigen E, Stuart B, Loewy RL, Mathalon DH, Calhoun VD. PMID: 29038030; PMCID: PMC5899692.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    216. Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Oct; 2(7):566-574. Abdallah CG, Averill CL, Salas R, Averill LA, Baldwin PR, Krystal JH, Mathew SJ, Mathalon DH. PMID: 29034354; PMCID: PMC5635826.
      View in: PubMed   Mentions: 56     Fields:    
    217. Exploration of clinical high-risk dropouts. Schizophr Res. 2018 05; 195:579-580. Stowkowy J, Liu L, Cadenhead KS, Tsuang MT, Cannon TD, Cornblatt BA, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Walker EF, Bearden CE, Mathalon DH, Addington J. PMID: 28964651; PMCID: PMC8126503.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    218. Biclustered Independent Component Analysis for Complex Biomarker and Subtype Identification from Structural Magnetic Resonance Images in Schizophrenia. Front Psychiatry. 2017; 8:179. Gupta CN, Castro E, Rachkonda S, van Erp TGM, Potkin S, Ford JM, Mathalon D, Lee HJ, Mueller BA, Greve DN, Andreassen OA, Agartz I, Mayer AR, Stephen J, Jung RE, Bustillo J, Calhoun VD, Turner JA. PMID: 29018368; PMCID: PMC5623192.
      View in: PubMed   Mentions: 13  
    219. Response to Targeted Cognitive Training Correlates with Change in Thalamic Volume in a Randomized Trial for Early Schizophrenia. Neuropsychopharmacology. 2018 02; 43(3):590-597. Ramsay IS, Fryer S, Boos A, Roach BJ, Fisher M, Loewy R, Vinogradov S, Mathalon DH. PMID: 28895568; PMCID: PMC5770762.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    220. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine. Schizophr Bull. 2017 09 01; 43(5):1123-1133. Forsyth JK, Bachman P, Mathalon DH, Roach BJ, Ye E, Asarnow RF. PMID: 28338977; PMCID: PMC5581900.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    221. Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety. Psychiatry Res. 2017 12; 258:462-468. Lu Y, Marshall C, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. PMID: 28886901; PMCID: PMC5915322.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    222. The role of a family history of psychosis for youth at clinical high risk of psychosis. Early Interv Psychiatry. 2019 Apr; 13(2):251-256. Georgopoulos G, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 28792113.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    223. Changes in symptom content from a clinical high-risk state to conversion to psychosis. Early Interv Psychiatry. 2019 Apr; 13(2):257-263. Marshall C, Lu Y, Lyngberg K, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. PMID: 28771938; PMCID: PMC5797503.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    224. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia. Schizophr Res. 2018 01; 191:87-94. Hamilton HK, D'Souza DC, Ford JM, Roach BJ, Kort NS, Ahn KH, Bhakta S, Ranganathan M, Mathalon DH. PMID: 28711472; PMCID: PMC5745273.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    225. Multimodal Fusion With Reference: Searching for Joint Neuromarkers of Working Memory Deficits in Schizophrenia. IEEE Trans Med Imaging. 2018 01; 37(1):93-105. Qi S, Calhoun VD, van Erp TGM, Bustillo J, Damaraju E, Turner JA, Du Y, Yang J, Chen J, Yu Q, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Jiang T, Sui J. PMID: 28708547; PMCID: PMC5750081.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    226. Trait aspects of auditory mismatch negativity predict response to auditory training in individuals with early illness schizophrenia. Neuropsychiatr Electrophysiol. 2017; 3. Biagianti B, Roach BJ, Fisher M, Loewy R, Ford JM, Vinogradov S, Mathalon DH. PMID: 28845238; PMCID: PMC5568850.
      View in: PubMed   Mentions: 26  
    227. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res. 2018 02; 192:357-363. Kline ER, Seidman LJ, Cornblatt BA, Woodberry KA, Bryant C, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Addington J. PMID: 28578922; PMCID: PMC6342468.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    228. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Dev Psychopathol. 2018 02; 30(1):39-47. Velthorst E, Zinberg J, Addington J, Cadenhead KS, Cannon TD, Carrión RE, Auther A, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Reichenberg A, Bearden CE. PMID: 28420458; PMCID: PMC5648633.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    229. Comorbid diagnoses for youth at clinical high risk of psychosis. Schizophr Res. 2017 12; 190:90-95. Addington J, Piskulic D, Liu L, Lockwood J, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Woods SW. PMID: 28372906; PMCID: PMC5731830.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    230. Cognitive correlates of visual neural plasticity in schizophrenia. Schizophr Res. 2017 12; 190:39-45. Jahshan C, Wynn JK, Mathalon DH, Green MF. PMID: 28336195.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    231. Modality-Dependent Impact of Hallucinations on Low-Frequency Fluctuations in Schizophrenia. Schizophr Bull. 2017 03 01; 43(2):389-396. Hare SM, Ford JM, Ahmadi A, Damaraju E, Belger A, Bustillo J, Lee HJ, Mathalon DH, Mueller BA, Preda A, van Erp TG, Potkin SG, Calhoun VD, Turner JA, Functional Imaging Biomedical Informatics Research Network. PMID: 27421792; PMCID: PMC5605256.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    232. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophr Res. 2017 11; 189:169-174. Chung Y, Haut KM, He G, van Erp TGM, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cannon TD, North American Prodrome Longitudinal Study (NAPLS) Consortium. PMID: 28245961; PMCID: PMC5572513.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    233. The Role of microRNA Expression in Cortical Development During Conversion to Psychosis. Neuropsychopharmacology. 2017 Oct; 42(11):2188-2195. Zheutlin AB, Jeffries CD, Perkins DO, Chung Y, Chekroud AM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Tsuang M, Cannon TD. PMID: 28186095; PMCID: PMC5603810.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    234. Abnormal Coupling Between Default Mode Network and Delta and Beta Band Brain Electric Activity in Psychotic Patients. Brain Connect. 2017 02; 7(1):34-44. Baenninger A, Palzes VA, Roach BJ, Mathalon DH, Ford JM, Koenig T. PMID: 27897031; PMCID: PMC5312599.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    235. Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls. Psychol Med. 2017 May; 47(7):1311-1322. Woolley JD, Chuang B, Fussell C, Scherer S, Biagianti B, Fulford D, Mathalon DH, Vinogradov S. PMID: 28091349; PMCID: PMC6939989.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    236. Neural mechanisms of mood-induced modulation of reality monitoring in schizophrenia. Cortex. 2017 06; 91:271-286. Subramaniam K, Ranasinghe KG, Mathalon D, Nagarajan S, Vinogradov S. PMID: 28162778; PMCID: PMC5749425.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    237. Insights into psychosis risk from leukocyte microRNA expression. Transl Psychiatry. 2016 12 13; 6(12):e981. Jeffries CD, Perkins DO, Chandler SD, Stark T, Yeo E, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Walker EF, Woods SW, Glatt SJ, Tsuang M. PMID: 27959328; PMCID: PMC5290334.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    238. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry. 2016 Dec 01; 73(12):1239-1248. Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW. PMID: 27806157; PMCID: PMC5511703.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    239. Neural Mechanisms of Positive Mood Induced Modulation of Reality Monitoring. Front Hum Neurosci. 2016; 10:581. Subramaniam K, Gill J, Slattery P, Shastri A, Mathalon DH, Nagarajan S, Vinogradov S. PMID: 27895571; PMCID: PMC5108806.
      View in: PubMed   Mentions: 11  
    240. Multisite reliability of MR-based functional connectivity. Neuroimage. 2017 02 01; 146:959-970. Noble S, Scheinost D, Finn ES, Shen X, Papademetris X, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TGM, Walker EF, Hamann S, Woods SW, Cannon TD, Constable RT. PMID: 27746386; PMCID: PMC5322153.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    241. Treatment Precedes Positive Symptoms in North American Adolescent and Young Adult Clinical High Risk Cohort. J Clin Child Adolesc Psychol. 2018 Jan-Feb; 47(1):69-78. Woodberry KA, Seidman LJ, Bryant C, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW. PMID: 27705009; PMCID: PMC5533647.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    242. Go/No Go task performance predicts cortical thickness in the caudal inferior frontal gyrus in young adults with and without ADHD. Brain Imaging Behav. 2016 09; 10(3):880-92. Newman E, Jernigan TL, Lisdahl KM, Tamm L, Tapert SF, Potkin SG, Mathalon D, Molina B, Bjork J, Castellanos FX, Swanson J, Kuperman JM, Bartsch H, Chen CH, Dale AM, Epstein JN, MTA Neuroimaging Group. PMID: 26404018; PMCID: PMC4808505.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    243. ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging Behav. 2016 09; 10(3):761-71. Rasmussen J, Casey BJ, van Erp TG, Tamm L, Epstein JN, Buss C, Bjork JM, Molina BS, Velanova K, Mathalon DH, Somerville L, Swanson JM, Wigal T, Arnold LE, Potkin SG, MTA Neuroimaging Group. PMID: 26489976; PMCID: PMC4840078.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    244. Using concurrent EEG and fMRI to probe the state of the brain in schizophrenia. Neuroimage Clin. 2016; 12:429-41. Ford JM, Roach BJ, Palzes VA, Mathalon DH. PMID: 27622140; PMCID: PMC5008052.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    245. Supervised multimodal fusion and its application in searching joint neuromarkers of working memory deficits in schizophrenia. Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug; 2016:4021-4026. Calhoun VD, van Erp TG, Damaraju E, Bustillo J, Turner JA, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Birn F. PMID: 28269167.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    246. Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research. Biol Psychiatry. 2016 07 15; 80(2):84-86. Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AFT, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA, Carter CS, Cook EH, Daskalakis ZJ, DiLeone RJ, Duman RS, Grace AA, Hariri AR, Harrison PJ, Hiroi N, Kenny PJ, Kleinman JE, Krystal AD, Lewis DA, Lipska BK, Marder SR, Mason GF, Mathalon DH, McClung CA, McDougle CJ, McIntosh AM, McMahon FJ, Mirnics K, Monteggia LM, Narendran R, Nestler EJ, Neumeister A, O'Donovan MC, Öngür D, Pariante CM, Paulus MP, Pearlson G, Phillips ML, Pine DS, Pizzagalli DA, Pletnikov MV, Ragland JD, Rapoport JL, Ressler KJ, Russo SJ, Sanacora G, Sawa A, Schatzberg AF, Shaham Y, Shamay-Tsoory SG, Sklar P, State MW, Stein MB, Strakowski SM, Taylor SF, Turecki G, Turetsky BI, Weissman MM, Zachariou V, Zarate CA, Zubieta JK. PMID: 27346079; PMCID: PMC6150945.
      View in: PubMed   Mentions: 1     Fields:    
    247. Comparison of brain activation patterns during executive function tasks in hoarding disorder and non-hoarding OCD. Psychiatry Res Neuroimaging. 2016 Sep 30; 255:50-9. Hough CM, Luks TL, Lai K, Vigil O, Guillory S, Nongpiur A, Fekri SM, Kupferman E, Mathalon DH, Mathews CA. PMID: 27522332; PMCID: PMC5014569.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    248. An Individualized Risk Calculator for Research in Prodromal Psychosis. Am J Psychiatry. 2016 Oct 01; 173(10):980-988. Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Kattan MW. PMID: 27363508; PMCID: PMC5048498.
      View in: PubMed   Mentions: 219     Fields:    Translation:Humans
    249. Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia. Biol Psychiatry. 2017 03 15; 81(6):514-524. Kort NS, Ford JM, Roach BJ, Gunduz-Bruce H, Krystal JH, Jaeger J, Reinhart RM, Mathalon DH. PMID: 27647218; PMCID: PMC5203970.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    250. Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Res Neuroimaging. 2016 Aug 30; 254:3-9. Buchy L, Mathalon DH, Cannon TD, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Addington J. PMID: 27289213; PMCID: PMC5037437.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    251. The Violent Content in Attenuated Psychotic Symptoms. Psychiatry Res. 2016 Aug 30; 242:61-66. Marshall C, Deighton S, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. PMID: 27259137; PMCID: PMC8130822.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    252. Traumatic brain injury in individuals at clinical high risk for psychosis. Schizophr Res. 2016 07; 174(1-3):77-81. Deighton S, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon D, Addington J. PMID: 27165121; PMCID: PMC5037435.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    253. Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for Psychosis. Schizophr Bull. 2016 09; 42(5):1234-42. McLaughlin D, Carrión RE, Auther AM, Olvet DM, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen RK, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Goldberg TE, Harvey PD, Cornblatt BA. PMID: 27105902; PMCID: PMC4988745.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    254. Reduced Amplitude of Low-Frequency Brain Oscillations in the Psychosis Risk Syndrome and Early Illness Schizophrenia. Neuropsychopharmacology. 2016 08; 41(9):2388-98. Fryer SL, Roach BJ, Wiley K, Loewy RL, Ford JM, Mathalon DH. PMID: 27067126; PMCID: PMC4946069.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    255. Higher Dimensional Meta-State Analysis Reveals Reduced Resting fMRI Connectivity Dynamism in Schizophrenia Patients. PLoS One. 2016; 11(3):e0149849. Miller RL, Yaesoubi M, Turner JA, Mathalon D, Preda A, Pearlson G, Adali T, Calhoun VD. PMID: 26981625; PMCID: PMC4794213.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    256. Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis. Schizophr Bull. 2016 07; 42 Suppl 1:S118-26. Loewy R, Fisher M, Schlosser DA, Biagianti B, Stuart B, Mathalon DH, Vinogradov S. PMID: 26903238; PMCID: PMC4960436.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    257. The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis. Schizophr Res. 2016 Apr; 172(1-3):29-34. Moskow DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, Woods SW, Walker EF. PMID: 26905038; PMCID: PMC4821739.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    258. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers. Schizophr Res. 2016 Apr; 172(1-3):106-13. Stone WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, McCarley RW, Heinssen R, Green MF, Nuechterlein K, Seidman LJ. PMID: 26896388; PMCID: PMC5410891.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    259. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Soc Psychiatry Psychiatr Epidemiol. 2016 Apr; 51(4):497-503. Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26851943; PMCID: PMC7012367.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    260. A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression. Psychother Psychosom. 2016; 85(2):99-110. Eisendrath SJ, Gillung E, Delucchi KL, Segal ZV, Nelson JC, McInnes LA, Mathalon DH, Feldman MD. PMID: 26808973; PMCID: PMC4756643.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    261. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophr Res. 2016 Mar; 171(1-3):176-81. Piskulic D, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26785807; PMCID: PMC5037438.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    262. Self-initiated actions result in suppressed auditory but amplified visual evoked components in healthy participants. Psychophysiology. 2016 May; 53(5):723-32. Mifsud NG, Oestreich LK, Jack BN, Ford JM, Roach BJ, Mathalon DH, Whitford TJ. PMID: 26751981.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    263. Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brain. Proc Natl Acad Sci U S A. 2015 Dec 15; 112(50):15331-6. Forsyth JK, Bachman P, Mathalon DH, Roach BJ, Asarnow RF. PMID: 26621715; PMCID: PMC4687562.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    264. Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. Psychiatry Res. 2015 Dec 30; 230(3):878-84. Buchy L, Seidman LJ, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26626949; PMCID: PMC5037441.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    265. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry. 2015 Nov 09; 15:276. Buchy L, Cannon TD, Anticevic A, Lyngberg K, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26553191; PMCID: PMC4640353.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    266. Neuropsychological profile in adult schizophrenia measured with the CMINDS. Psychiatry Res. 2015 Dec 30; 230(3):826-34. van Erp TG, Preda A, Turner JA, Callahan S, Calhoun VD, Bustillo JR, Lim KO, Mueller B, Brown GG, Vaidya JG, McEwen S, Belger A, Voyvodic J, Mathalon DH, Nguyen D, Ford JM, Potkin SG, FBIRN. PMID: 26586142; PMCID: PMC4692593.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    267. Neural Correlates of Schizophrenia Negative Symptoms: Distinct Subtypes Impact Dissociable Brain Circuits. Mol Neuropsychiatry. 2015 Dec; 1(4):191-200. Shaffer JJ, Peterson MJ, McMahon MA, Bizzell J, Calhoun V, van Erp TG, Ford JM, Lauriello J, Lim KO, Manoach DS, McEwen SC, Mathalon DH, O'Leary D, Potkin SG, Preda A, Turner J, Voyvodic J, Wible CG, Belger A. PMID: 27606313; PMCID: PMC4996000.
      View in: PubMed   Mentions: 24  
    268. Anxiety in youth at clinical high risk for psychosis. Early Interv Psychiatry. 2017 12; 11(6):480-487. McAusland L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. PMID: 26456932; PMCID: PMC4912451.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    269. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophr Res. 2015 Dec; 169(1-3):169-177. Perkins DO, Jeffries CD, Cornblatt BA, Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen R, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. PMID: 26441004; PMCID: PMC4681584.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    270. Error-related brain activity dissociates hoarding disorder from obsessive-compulsive disorder. Psychol Med. 2016 Jan; 46(2):367-79. Mathews CA, Perez VB, Roach BJ, Fekri S, Vigil O, Kupferman E, Mathalon DH. PMID: 26415671; PMCID: PMC5079649.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    271. The effect of cognitive challenge on delay discounting. Neuroimage. 2016 Jan 01; 124(Pt A):733-739. Aranovich GJ, McClure SM, Fryer S, Mathalon DH. PMID: 26394377; PMCID: PMC5858572.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    272. The Function Biomedical Informatics Research Network Data Repository. Neuroimage. 2016 Jan 01; 124(Pt B):1074-1079. Keator DB, van Erp TGM, Turner JA, Glover GH, Mueller BA, Liu TT, Voyvodic JT, Rasmussen J, Calhoun VD, Lee HJ, Toga AW, McEwen S, Ford JM, Mathalon DH, Diaz M, O'Leary DS, Jeremy Bockholt H, Gadde S, Preda A, Wible CG, Stern HS, Belger A, McCarthy G, Ozyurt B, Potkin SG, FBIRN. PMID: 26364863; PMCID: PMC4651841.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    273. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. JAMA Psychiatry. 2015 Sep; 72(9):882-91. Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD. PMID: 26267151; PMCID: PMC4892891.
      View in: PubMed   Mentions: 176     Fields:    Translation:Humans
    274. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016 04; 21(4):585. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Hulshoff Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA. PMID: 26283641; PMCID: PMC5751698.
      View in: PubMed   Mentions: 127     Fields:    
    275. Neural Oscillations and Synchrony in Brain Dysfunction and Neuropsychiatric Disorders: It's About Time. JAMA Psychiatry. 2015 Aug; 72(8):840-4. Mathalon DH, Sohal VS. PMID: 26039190.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    276. Multidimensional frequency domain analysis of full-volume fMRI reveals significant effects of age, gender, and mental illness on the spatiotemporal organization of resting-state brain activity. Front Neurosci. 2015; 9:203. Miller RL, Erhardt EB, Agcaoglu O, Allen EA, Michael AM, Turner JA, Bustillo J, Ford JM, Mathalon DH, Van Erp TG, Potkin S, Preda A, Pearlson G, Calhoun VD. PMID: 26136646; PMCID: PMC4468831.
      View in: PubMed   Mentions: 7  
    277. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016 Apr; 21(4):547-53. van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MW, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NE, Hulshoff Pol HE, Pol HE, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA. PMID: 26033243; PMCID: PMC4668237.
      View in: PubMed   Mentions: 380     Fields:    Translation:Humans
    278. A Preliminary Study: Efficacy of Mindfulness-Based Cognitive Therapy versus Sertraline as First-line Treatments for Major Depressive Disorder. Mindfulness (N Y). 2015 Jun 01; 6(3):475-482. Eisendrath SJ, Gillung E, Delucchi K, Mathalon DH, Yang TT, Satre DD, Rosser R, Sipe WE, Wolkowitz OM. PMID: 26085853; PMCID: PMC4465797.
      View in: PubMed   Mentions: 9  
    279. Subnormal sensory attenuation to self-generated speech in schizotypy: Electrophysiological evidence for a 'continuum of psychosis'. Int J Psychophysiol. 2015 Aug; 97(2):131-8. Oestreich LK, Mifsud NG, Ford JM, Roach BJ, Mathalon DH, Whitford TJ. PMID: 26027781; PMCID: PMC4607510.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    280. Demographic correlates of attenuated positive psychotic symptoms. Schizophr Res. 2015 Aug; 166(1-3):31-6. Waford RN, MacDonald A, Goines K, Novacek DM, Trotman HD, Elaine F W, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. PMID: 25999040; PMCID: PMC4767147.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    281. Theory of Mind, Emotion Recognition and Social Perception in Individuals at Clinical High Risk for Psychosis: findings from the NAPLS-2 cohort. Schizophr Res Cogn. 2015 Sep; 2(3):133-139. Barbato M, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. PMID: 27695675; PMCID: PMC5041592.
      View in: PubMed   Mentions: 25  
    282. Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia. Neuropsychopharmacology. 2015 Nov; 40(12):2705-14. Fryer SL, Roach BJ, Ford JM, Turner JA, van Erp TG, Voyvodic J, Preda A, Belger A, Bustillo J, O'Leary D, Mueller BA, Lim KO, McEwen SC, Calhoun VD, Diaz M, Glover G, Greve D, Wible CG, Vaidya J, Potkin SG, Mathalon DH. PMID: 25944410; PMCID: PMC4864646.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    283. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms. J Nerv Ment Dis. 2015 May; 203(5):328-35. Addington J, Liu L, Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, McGlashan TH. PMID: 25919383; PMCID: PMC4417745.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    284. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders. Mol Neuropsychiatry. 2015 May 01; 1(1):13-22. Chung Y, Jacobson A, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R, Cannon TD. PMID: 26005673; PMCID: PMC4436673.
      View in: PubMed   Mentions: 13  
    285. Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans. Neuropsychopharmacology. 2015 Aug; 40(9):2124-34. Cortes-Briones J, Skosnik PD, Mathalon D, Cahill J, Pittman B, Williams A, Sewell RA, Ranganathan M, Roach B, Ford J, D'Souza DC. PMID: 25709097; PMCID: PMC4613601.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    286. Core Schemas in Youth at Clinical High Risk for Psychosis. Behav Cogn Psychother. 2016 Mar; 44(2):203-13. Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Heinssen R, Addington J. PMID: 25896713.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    287. Cortical Suppression to Delayed Self-Initiated Auditory Stimuli in Schizotypy: Neurophysiological Evidence for a Continuum of Psychosis. Clin EEG Neurosci. 2016 Jan; 47(1):3-10. Oestreich LK, Mifsud NG, Ford JM, Roach BJ, Mathalon DH, Whitford TJ. PMID: 25898988.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    288. Functional magnetic resonance imaging of motor cortex activation in schizophrenia. J Korean Med Sci. 2015 May; 30(5):625-31. Lee HJ, Preda A, Ford JM, Mathalon DH, Keator DB, van Erp TG, Turner JA, Potkin SG. PMID: 25931795; PMCID: PMC4414648.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    289. The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans. Biol Psychiatry. 2015 Dec 01; 78(11):805-13. Cortes-Briones JA, Cahill JD, Skosnik PD, Mathalon DH, Williams A, Sewell RA, Roach BJ, Ford JM, Ranganathan M, D'Souza DC. PMID: 25913109; PMCID: PMC4627857.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    290. Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study. Hum Brain Mapp. 2015 Jul; 36(7):2558-79. Gee DG, McEwen SC, Forsyth JK, Haut KM, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos H, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Constable T, Cannon TD. PMID: 25821147; PMCID: PMC4478164.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    291. Substance use in individuals at clinical high risk of psychosis. Psychol Med. 2015 Aug; 45(11):2275-84. Buchy L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R, Bearden CE, Mathalon D, Addington J. PMID: 25727300; PMCID: PMC8182984.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    292. Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients. Biol Psychol. 2015 Feb; 105:130-7. Hay RA, Roach BJ, Srihari VH, Woods SW, Ford JM, Mathalon DH. PMID: 25603283; PMCID: PMC4336819.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    293. Oxytocin administration selectively improves olfactory detection thresholds for lyral in patients with schizophrenia. Psychoneuroendocrinology. 2015 Mar; 53:217-22. Woolley JD, Lam O, Chuang B, Ford JM, Mathalon DH, Vinogradov S. PMID: 25637811; PMCID: PMC4503321.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    294. Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis. Schizophr Bull. 2015 Sep; 41(5):1133-42. Gupta CN, Calhoun VD, Rachakonda S, Chen J, Patel V, Liu J, Segall J, Franke B, Zwiers MP, Arias-Vasquez A, Buitelaar J, Fisher SE, Fernandez G, van Erp TG, Potkin S, Ford J, Mathalon D, McEwen S, Lee HJ, Mueller BA, Greve DN, Andreassen O, Agartz I, Gollub RL, Sponheim SR, Ehrlich S, Wang L, Pearlson G, Glahn DC, Sprooten E, Mayer AR, Stephen J, Jung RE, Canive J, Bustillo J, Turner JA. PMID: 25548384; PMCID: PMC4535628.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    295. Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr Res. 2014 Dec; 160(1-3):104-9. Trotman HD, Holtzman CW, Walker EF, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen RK, Mathalon DH, Tsuang MT, Perkins DO, Seidman LJ, Woods SW, McGlashan TH. PMID: 25443665; PMCID: PMC4593703.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    296. An incongruent reality: the N400 in relation to psychosis and recovery. Schizophr Res. 2014 Dec; 160(1-3):208-15. Jackson F, Foti D, Kotov R, Perlman G, Mathalon DH, Proudfit GH. PMID: 25449716; PMCID: PMC4258120.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    297. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophr Bull. 2015 Mar; 41(2):419-28. Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. PMID: 25103207; PMCID: PMC4332942.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    298. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations. Psychiatry Res. 2014 Dec 30; 220(3):1077-83. Fulford D, Pearson R, Stuart BK, Fisher M, Mathalon DH, Vinogradov S, Loewy RL. PMID: 25278477; PMCID: PMC4258147.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    299. Impact of autocorrelation on functional connectivity. Neuroimage. 2014 Nov 15; 102 Pt 2:294-308. Arbabshirani MR, Damaraju E, Phlypo R, Plis S, Allen E, Ma S, Mathalon D, Preda A, Vaidya JG, Adali T, Calhoun VD. PMID: 25072392; PMCID: PMC4253536.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    300. Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia. Neuroimage Clin. 2014; 5:298-308. Damaraju E, Allen EA, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TG, Calhoun VD. PMID: 25161896; PMCID: PMC4141977.
      View in: PubMed   Mentions: 460     Fields:    Translation:Humans
    301. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015 Jan 15; 77(2):147-57. Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R, North American Prodrome Longitudinal Study Consortium. PMID: 25034946; PMCID: PMC4264996.
      View in: PubMed   Mentions: 269     Fields:    Translation:Humans
    302. Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology. 2014 Sep; 47:116-25. Woolley JD, Chuang B, Lam O, Lai W, O'Donovan A, Rankin KP, Mathalon DH, Vinogradov S. PMID: 25001961; PMCID: PMC4280262.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    303. Reliability of functional magnetic resonance imaging activation during working memory in a multi-site study: analysis from the North American Prodrome Longitudinal Study. Neuroimage. 2014 Aug 15; 97:41-52. Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet DM, Mathalon DH, McGlashan TH, Perkins DO, Belger A, Seidman LJ, Thermenos HW, Tsuang MT, van Erp TG, Walker EF, Hamann S, Woods SW, Qiu M, Cannon TD. PMID: 24736173; PMCID: PMC4065837.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    304. Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol. BMC Complement Altern Med. 2014 Mar 11; 14:95. Eisendrath SJ, Gillung EP, Delucchi KL, Chartier M, Mathalon DH, Sullivan JC, Segal ZV, Feldman MD. PMID: 24612825; PMCID: PMC3995768.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    305. Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia. Schizophr Bull. 2015 Jan; 41(1):223-32. Ford JM, Palzes VA, Roach BJ, Potkin SG, van Erp TG, Turner JA, Mueller BA, Calhoun VD, Voyvodic J, Belger A, Bustillo J, Vaidya JG, Preda A, McEwen SC, Functional Imaging Biomedical Informatics Research Network, Mathalon DH. PMID: 24619536; PMCID: PMC4266287.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    306. A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. Psychiatry Res. 2014 Apr 30; 222(1-2):10-6. van Erp TG, Greve DN, Rasmussen J, Turner J, Calhoun VD, Young S, Mueller B, Brown GG, McCarthy G, Glover GH, Lim KO, Bustillo JR, Belger A, McEwen S, Voyvodic J, Mathalon DH, Keator D, Preda A, Nguyen D, Ford JM, Potkin SG. PMID: 24650452; PMCID: PMC4059082.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    307. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans. Front Psychiatry. 2014; 5:3. Mathalon DH, Ahn KH, Perry EB, Cho HS, Roach BJ, Blais RK, Bhakta S, Ranganathan M, Ford JM, D'Souza DC. PMID: 24478731; PMCID: PMC3900858.
      View in: PubMed   Mentions: 17  
    308. Action planning and predictive coding when speaking. Neuroimage. 2014 May 01; 91:91-8. Wang J, Mathalon DH, Roach BJ, Reilly J, Keedy SK, Sweeney JA, Ford JM. PMID: 24423729; PMCID: PMC3965634.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    309. Auditory cortex processes variation in our own speech. PLoS One. 2013; 8(12):e82925. Sitek KR, Mathalon DH, Roach BJ, Houde JF, Niziolek CA, Ford JM. PMID: 24349399; PMCID: PMC3862760.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    310. Converting positive and negative symptom scores between PANSS and SAPS/SANS. Schizophr Res. 2014 Jan; 152(1):289-94. van Erp TG, Preda A, Nguyen D, Faziola L, Turner J, Bustillo J, Belger A, Lim KO, McEwen S, Voyvodic J, Mathalon DH, Ford J, Potkin SG. PMID: 24332632; PMCID: PMC3966195.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    311. Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity. Biol Psychiatry. 2014 Mar 15; 75(6):459-69. Perez VB, Woods SW, Roach BJ, Ford JM, McGlashan TH, Srihari VH, Mathalon DH. PMID: 24050720; PMCID: PMC4028131.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    312. Deficient Suppression of Default Mode Regions during Working Memory in Individuals with Early Psychosis and at Clinical High-Risk for Psychosis. Front Psychiatry. 2013; 4:92. Fryer SL, Woods SW, Kiehl KA, Calhoun VD, Pearlson GD, Roach BJ, Ford JM, Srihari VH, McGlashan TH, Mathalon DH. PMID: 24032017; PMCID: PMC3768116.
      View in: PubMed   Mentions: 37  
    313. Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. Hum Brain Mapp. 2014 May; 35(5):2424-34. Cannon TD, Sun F, McEwen SJ, Papademetris X, He G, van Erp TG, Jacobson A, Bearden CE, Walker E, Hu X, Zhou L, Seidman LJ, Thermenos HW, Cornblatt B, Olvet DM, Perkins D, Belger A, Cadenhead K, Tsuang M, Mirzakhanian H, Addington J, Frayne R, Woods SW, McGlashan TH, Constable RT, Qiu M, Mathalon DH, Thompson P, Toga AW. PMID: 23982962; PMCID: PMC3843968.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    314. A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophrenia. Front Neurosci. 2013; 7:137. Turner JA, Damaraju E, van Erp TG, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, Bustillo J, McEwen S, Potkin SG, Calhoun VD. PMID: 23964193; PMCID: PMC3737471.
      View in: PubMed   Mentions: 90  
    315. Between-site reliability of startle prepulse inhibition across two early psychosis consortia. Neuroreport. 2013 Aug 07; 24(11):626-30. Cadenhead KS, Addington J, Cannon TD, Cornblatt BA, de la Fuente-Sandoval C, Mathalon DH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bachman P, Belger A, Carrión RE, Donkers FC, Duncan E, Johannesen J, León-Ortiz P, Light G, Mondragón A, Niznikiewicz M, Nunag J, Roach BJ, Solís-Vivanco R, North American Prodromal Longitudinal Studies Consortium. PMID: 23799460; PMCID: PMC4135529.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    316. Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation. Biol Psychiatry. 2014 Mar 01; 75(5):398-405. van Erp TG, Guella I, Vawter MP, Turner J, Brown GG, McCarthy G, Greve DN, Glover GH, Calhoun VD, Lim KO, Bustillo JR, Belger A, Ford JM, Mathalon DH, Diaz M, Preda A, Nguyen D, Macciardi F, Potkin SG. PMID: 23910899; PMCID: PMC4428556.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    317. Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011. Schizophr Res. 2013 Aug; 148(1-3):99-104. Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. PMID: 23787224; PMCID: PMC3867209.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    318. Did I do that? Abnormal predictive processes in schizophrenia when button pressing to deliver a tone. Schizophr Bull. 2014 Jul; 40(4):804-12. Ford JM, Palzes VA, Roach BJ, Mathalon DH. PMID: 23754836; PMCID: PMC4059422.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    319. An application of item response theory to fMRI data: prospects and pitfalls. Psychiatry Res. 2013 Jun 30; 212(3):167-74. Thomas ML, Brown GG, Thompson WK, Voyvodic J, Greve DN, Turner JA, Mathalon DH, Ford J, Wible CG, Potkin SG, FBIRN. PMID: 23642468; PMCID: PMC3775707.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    320. Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms. Schizophr Res. 2013 Jun; 147(1):125-131. Fulford D, Niendam TA, Floyd EG, Carter CS, Mathalon DH, Vinogradov S, Stuart BK, Loewy RL. PMID: 23587696; PMCID: PMC3663589.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    321. Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study. Biol Psychiatry. 2013 Sep 15; 74(6):410-7. Walker EF, Trotman HD, Pearce BD, Addington J, Cadenhead KS, Cornblatt BA, Heinssen R, Mathalon DH, Perkins DO, Seidman LJ, Tsuang MT, Cannon TD, McGlashan TH, Woods SW. PMID: 23562006; PMCID: PMC3707958.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    322. Early auditory gamma-band responses in patients at clinical high risk for schizophrenia. Suppl Clin Neurophysiol. 2013; 62:147-62. Perez VB, Roach BJ, Woods SW, Srihari VH, McGlashan TH, Ford JM, Mathalon DH. PMID: 24053038; PMCID: PMC4120874.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    323. Converging evidence for gamma synchrony deficits in schizophrenia. Suppl Clin Neurophysiol. 2013; 62:163-80. Roach BJ, Ford JM, Hoffman RE, Mathalon DH. PMID: 24053039; PMCID: PMC4165558.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    324. Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their nonpsychotic first-degree relatives. Schizophr Bull. 2013 Nov; 39(6):1272-80. Ford JM, Mathalon DH, Roach BJ, Keedy SK, Reilly JL, Gershon ES, Sweeney JA. PMID: 23155183; PMCID: PMC3796076.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    325. Differential brain response to alcohol cue distractors across stages of alcohol dependence. Biol Psychol. 2013 Feb; 92(2):282-91. Fryer SL, Jorgensen KW, Yetter EJ, Daurignac EC, Watson TD, Shanbhag H, Krystal JH, Mathalon DH. PMID: 23131612; PMCID: PMC3947923.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    326. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012 Dec; 142(1-3):77-82. Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington JA, Cannon TD. PMID: 23043872; PMCID: PMC3502644.
      View in: PubMed   Mentions: 153     Fields:    Translation:Humans
    327. Neurobiology of schizophrenia: search for the elusive correlation with symptoms. Front Hum Neurosci. 2012; 6:136. Mathalon DH, Ford JM. PMID: 22654745; PMCID: PMC3360476.
      View in: PubMed   Mentions: 29  
    328. Reliability of the amplitude of low-frequency fluctuations in resting state fMRI in chronic schizophrenia. Psychiatry Res. 2012 Mar 31; 201(3):253-5. Turner JA, Chen H, Mathalon DH, Allen EA, Mayer AR, Abbott CC, Calhoun VD, Bustillo J. PMID: 22541511; PMCID: PMC3361647.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    329. Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry. 2012 Mar 15; 71(6):512-20. Cavus I, Reinhart RM, Roach BJ, Gueorguieva R, Teyler TJ, Clapp WC, Ford JM, Krystal JH, Mathalon DH. PMID: 22364738; PMCID: PMC3292767.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    330. Neurophysiological studies of auditory verbal hallucinations. Schizophr Bull. 2012 Jun; 38(4):715-23. Ford JM, Dierks T, Fisher DJ, Herrmann CS, Hubl D, Kindler J, Koenig T, Mathalon DH, Spencer KM, Strik W, van Lutterveld R. PMID: 22368236; PMCID: PMC3406526.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    331. An ICA with reference approach in identification of genetic variation and associated brain networks. Front Hum Neurosci. 2012; 6:21. Liu J, Ghassemi MM, Michael AM, Boutte D, Wells W, Perrone-Bizzozero N, Macciardi F, Mathalon DH, Ford JM, Potkin SG, Turner JA, Calhoun VD. PMID: 22371699; PMCID: PMC3284145.
      View in: PubMed   Mentions: 15  
    332. Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans. Neuropsychopharmacology. 2012 Jun; 37(7):1632-46. D'Souza DC, Fridberg DJ, Skosnik PD, Williams A, Roach B, Singh N, Carbuto M, Elander J, Schnakenberg A, Pittman B, Sewell RA, Ranganathan M, Mathalon D. PMID: 22334121; PMCID: PMC3358754.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    333. Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. J Magn Reson Imaging. 2012 Jul; 36(1):39-54. Glover GH, Mueller BA, Turner JA, van Erp TG, Liu TT, Greve DN, Voyvodic JT, Rasmussen J, Brown GG, Keator DB, Calhoun VD, Lee HJ, Ford JM, Mathalon DH, Diaz M, O'Leary DS, Gadde S, Preda A, Lim KO, Wible CG, Stern HS, Belger A, McCarthy G, Ozyurt B, Potkin SG. PMID: 22314879; PMCID: PMC3349791.
      View in: PubMed   Mentions: 141     Fields:    Translation:Humans
    334. Neurophysiology of a possible fundamental deficit in schizophrenia. World Psychiatry. 2012 Feb; 11(1):58-60. Ford JM, Perez VB, Mathalon DH. PMID: 22295012; PMCID: PMC3266755.
      View in: PubMed   Mentions: 4  
    335. Error-related negativity in individuals with obsessive-compulsive symptoms: toward an understanding of hoarding behaviors. Biol Psychol. 2012 Feb; 89(2):487-94. Mathews CA, Perez VB, Delucchi KL, Mathalon DH. PMID: 22227169; PMCID: PMC3292435.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    336. Error monitoring dysfunction across the illness course of schizophrenia. J Abnorm Psychol. 2012 May; 121(2):372-87. Perez VB, Ford JM, Roach BJ, Woods SW, McGlashan TH, Srihari VH, Loewy RL, Vinogradov S, Mathalon DH. PMID: 22060947; PMCID: PMC3358508.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    337. Glutamatergic modulation of auditory information processing in the human brain. Biol Psychiatry. 2012 Jun 01; 71(11):969-77. Gunduz-Bruce H, Reinhart RM, Roach BJ, Gueorguieva R, Oliver S, D'Souza DC, Ford JM, Krystal JH, Mathalon DH. PMID: 22036036; PMCID: PMC3290754.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    338. Auditory cortex responsiveness during talking and listening: early illness schizophrenia and patients at clinical high-risk for psychosis. Schizophr Bull. 2012 Nov; 38(6):1216-24. Perez VB, Ford JM, Roach BJ, Loewy RL, Stuart BK, Vinogradov S, Mathalon DH. PMID: 21993915; PMCID: PMC3494053.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    339. Challenges associated with application of clinical staging models to psychotic disorders. Biol Psychiatry. 2011 Oct 01; 70(7):600-1. Mathalon DH. PMID: 21924130; PMCID: PMC4096294.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    340. Anticipating the future: automatic prediction failures in schizophrenia. Int J Psychophysiol. 2012 Feb; 83(2):232-9. Ford JM, Mathalon DH. PMID: 21959054; PMCID: PMC3288329.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimals
    341. Using brain imaging measures in studies of procognitive pharmacologic agents in schizophrenia: psychometric and quality assurance considerations. Biol Psychiatry. 2011 Jul 01; 70(1):13-8. Barch DM, Mathalon DH. PMID: 21334602; PMCID: PMC4073232.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    342. Frontally mediated inhibitory processing and white matter microstructure: age and alcoholism effects. Psychopharmacology (Berl). 2011 Feb; 213(4):669-79. Colrain IM, Sullivan EV, Ford JM, Mathalon DH, McPherson SL, Roach BJ, Crowley KE, Pfefferbaum A. PMID: 21161189; PMCID: PMC3033525.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    343. A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biol Psychiatry. 2011 Jul 01; 70(1):28-34. Luck SJ, Mathalon DH, O'Donnell BF, Hämäläinen MS, Spencer KM, Javitt DC, Uhlhaas PJ. PMID: 21111401; PMCID: PMC3116072.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansAnimals
    344. A novel method for quantifying scanner instability in fMRI. Magn Reson Med. 2011 Apr; 65(4):1053-61. Greve DN, Mueller BA, Liu T, Turner JA, Voyvodic J, Yetter E, Diaz M, McCarthy G, Wallace S, Roach BJ, Ford JM, Mathalon DH, Calhoun VD, Wible CG, Brown GG, Potkin SG, Glover G. PMID: 21413069; PMCID: PMC3117086.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    345. The corollary discharge in humans is related to synchronous neural oscillations. J Cogn Neurosci. 2011 Oct; 23(10):2892-904. Chen CM, Mathalon DH, Roach BJ, Cavus I, Spencer DD, Ford JM. PMID: 20946054; PMCID: PMC4155919.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    346. Multisite reliability of cognitive BOLD data. Neuroimage. 2011 Feb 01; 54(3):2163-75. Brown GG, Mathalon DH, Stern H, Ford J, Mueller B, Greve DN, McCarthy G, Voyvodic J, Glover G, Diaz M, Yetter E, Ozyurt IB, Jorgensen KW, Wible CG, Turner JA, Thompson WK, Potkin SG, Function Biomedical Informatics Research Network. PMID: 20932915; PMCID: PMC3009557.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    347. Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr Bull. 2012 May; 38(3):486-94. Whitford TJ, Ford JM, Mathalon DH, Kubicki M, Shenton ME. PMID: 20855415; PMCID: PMC3329979.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    348. Relationships between pre-stimulus γ power and subsequent P300 and reaction time breakdown in schizophrenia. Int J Psychophysiol. 2011 Jan; 79(1):16-24. Reinhart RM, Mathalon DH, Roach BJ, Ford JM. PMID: 20816708; PMCID: PMC3033488.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    349. Long-term potentiation (LTP) of human sensory-evoked potentials. Wiley Interdiscip Rev Cogn Sci. 2010 Sep; 1(5):766-773. Kirk IJ, McNair NA, Hamm JP, Clapp WC, Mathalon DH, Cavus I, Teyler TJ. PMID: 26271660.
      View in: PubMed   Mentions: 17     Fields:    
    350. Electrophysiological and diffusion tensor imaging evidence of delayed corollary discharges in patients with schizophrenia. Psychol Med. 2011 May; 41(5):959-69. Whitford TJ, Mathalon DH, Shenton ME, Roach BJ, Bammer R, Adcock RA, Bouix S, Kubicki M, De Siebenthal J, Rausch AC, Schneiderman JS, Ford JM. PMID: 20663254; PMCID: PMC3807011.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    351. Assessing corollary discharge in humans using noninvasive neurophysiological methods. Nat Protoc. 2010 Jun; 5(6):1160-8. Ford JM, Roach BJ, Mathalon DH. PMID: 20539291; PMCID: PMC4051441.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    352. When it's time for a change: failures to track context in schizophrenia. Int J Psychophysiol. 2010 Oct; 78(1):3-13. Ford JM, Roach BJ, Miller RM, Duncan CC, Hoffman RE, Mathalon DH. PMID: 20580752; PMCID: PMC4143242.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    353. Working memory overload: fronto-limbic interactions and effects on subsequent working memory function. Brain Imaging Behav. 2010 Mar; 4(1):96-108. Yun RJ, Krystal JH, Mathalon DH. PMID: 20503117; PMCID: PMC2854358.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    354. Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder. Front Hum Neurosci. 2010; 3:70. Mathalon DH, Hoffman RE, Watson TD, Miller RM, Roach BJ, Ford JM. PMID: 20140266; PMCID: PMC2816168.
      View in: PubMed   Mentions: 24  
    355. Automatic semantic priming abnormalities in schizophrenia. Int J Psychophysiol. 2010 Feb; 75(2):157-66. Mathalon DH, Roach BJ, Ford JM. PMID: 19995582; PMCID: PMC4106427.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    356. Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum Brain Mapp. 2009 Nov; 30(11):3795-811. Kim DI, Manoach DS, Mathalon DH, Turner JA, Mannell M, Brown GG, Ford JM, Gollub RL, White T, Wible C, Belger A, Bockholt HJ, Clark VP, Lauriello J, O'Leary D, Mueller BA, Lim KO, Andreasen N, Potkin SG, Calhoun VD. PMID: 19434601; PMCID: PMC3058491.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    357. Error detection failures in schizophrenia: ERPs and FMRI. Int J Psychophysiol. 2009 Aug; 73(2):109-17. Mathalon DH, Jorgensen KW, Roach BJ, Ford JM. PMID: 19414043; PMCID: PMC4005823.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    358. Auditory oddball deficits in schizophrenia: an independent component analysis of the fMRI multisite function BIRN study. Schizophr Bull. 2009 Jan; 35(1):67-81. Kim DI, Mathalon DH, Ford JM, Mannell M, Turner JA, Brown GG, Belger A, Gollub R, Lauriello J, Wible C, O'Leary D, Lim K, Toga A, Potkin SG, Birn F, Calhoun VD. PMID: 19074498; PMCID: PMC2643962.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    359. Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophr Bull. 2009 Jan; 35(1):19-31. Potkin SG, Turner JA, Brown GG, McCarthy G, Greve DN, Glover GH, Manoach DS, Belger A, Diaz M, Wible CG, Ford JM, Mathalon DH, Gollub R, Lauriello J, O'Leary D, van Erp TG, Toga AW, Preda A, Lim KO, FBIRN. PMID: 19042912; PMCID: PMC2643959.
      View in: PubMed   Mentions: 172     Fields:    Translation:Humans
    360. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull. 2009 Jan; 35(1):96-108. Potkin SG, Turner JA, Guffanti G, Lakatos A, Fallon JH, Nguyen DD, Mathalon D, Ford J, Lauriello J, Macciardi F, FBIRN. PMID: 19023125; PMCID: PMC2643953.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    361. Brain-performance correlates of working memory retrieval in schizophrenia: a cognitive modeling approach. Schizophr Bull. 2009 Jan; 35(1):32-46. Brown GG, McCarthy G, Bischoff-Grethe A, Ozyurt B, Greve D, Potkin SG, Turner JA, Notestine R, Calhoun VD, Ford JM, Mathalon D, Manoach DS, Gadde S, Glover GH, Wible CG, Belger A, Gollub RL, Lauriello J, O'Leary D, Lim KO. PMID: 19023127; PMCID: PMC2643949.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    362. Tuning in to the voices: a multisite FMRI study of auditory hallucinations. Schizophr Bull. 2009 Jan; 35(1):58-66. Ford JM, Roach BJ, Jorgensen KW, Turner JA, Brown GG, Notestine R, Bischoff-Grethe A, Greve D, Wible C, Lauriello J, Belger A, Mueller BA, Calhoun V, Preda A, Keator D, O'Leary DS, Lim KO, Glover G, Potkin SG, FBIRN, Mathalon DH. PMID: 18987102; PMCID: PMC2643968.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    363. fMRI activity correlated with auditory hallucinations during performance of a working memory task: data from the FBIRN consortium study. Schizophr Bull. 2009 Jan; 35(1):47-57. Wible CG, Lee K, Molina I, Hashimoto R, Preus AP, Roach BJ, Ford JM, Mathalon DH, McCarthey G, Turner JA, Potkin SG, O'Leary D, Belger A, Diaz M, Voyvodic J, Brown GG, Notestine R, Greve D, Lauriello J, FBIRN. PMID: 18990710; PMCID: PMC2643958.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    364. Modulation of the cortical processing of novel and target stimuli by drugs affecting glutamate and GABA neurotransmission. Int J Neuropsychopharmacol. 2009 Apr; 12(3):357-70. Watson TD, Petrakis IL, Edgecombe J, Perrino A, Krystal JH, Mathalon DH. PMID: 18771605; PMCID: PMC2900256.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    365. Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophr Bull. 2008 Sep; 34(5):907-26. Roach BJ, Mathalon DH. PMID: 18684772; PMCID: PMC2632478.
      View in: PubMed   Mentions: 201     Fields:    Translation:Humans
    366. An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients. Schizophr Res. 2008 Sep; 104(1-3):85-95. Meda SA, Bhattarai M, Morris NA, Astur RS, Calhoun VD, Mathalon DH, Kiehl KA, Pearlson GD. PMID: 18678469; PMCID: PMC2577216.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    367. Divergent approaches converge on frontal lobe dysfunction in schizophrenia. Am J Psychiatry. 2008 Aug; 165(8):944-8. Mathalon DH, Ford JM. PMID: 18676596; PMCID: PMC2671635.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    368. Test-retest and between-site reliability in a multicenter fMRI study. Hum Brain Mapp. 2008 Aug; 29(8):958-72. Friedman L, Stern H, Brown GG, Mathalon DH, Turner J, Glover GH, Gollub RL, Lauriello J, Lim KO, Cannon T, Greve DN, Bockholt HJ, Belger A, Mueller B, Doty MJ, He J, Wells W, Smyth P, Pieper S, Kim S, Kubicki M, Vangel M, Potkin SG. PMID: 17636563; PMCID: PMC3670112.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    369. Neural synchrony in schizophrenia. Schizophr Bull. 2008 Sep; 34(5):904-6. Ford JM, Mathalon DH. PMID: 18658126; PMCID: PMC2632484.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    370. The dependence of P300 amplitude on gamma synchrony breaks down in schizophrenia. Brain Res. 2008 Oct 15; 1235:133-42. Ford JM, Roach BJ, Hoffman RS, Mathalon DH. PMID: 18621027; PMCID: PMC3230270.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    371. Corollary discharge dysfunction in schizophrenia: evidence for an elemental deficit. Clin EEG Neurosci. 2008 Apr; 39(2):82-6. Mathalon DH, Ford JM. PMID: 18450174.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    372. Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls. Neuroimage. 2008 Apr 15; 40(3):1181-94. Friedman L, Turner JA, Stern H, Mathalon DH, Trondsen LC, Potkin SG. PMID: 18289881; PMCID: PMC2312339.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    373. Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study. Br J Psychiatry Suppl. 2007 Dec; 51:s96-101. Woods SW, Tully EM, Walsh BC, Hawkins KA, Callahan JL, Cohen SJ, Mathalon DH, Miller TJ, McGlashan TH. PMID: 18055946.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    374. Diffusion tensor imaging in schizophrenia: relationship to symptoms. Schizophr Res. 2008 Jan; 98(1-3):157-62. Skelly LR, Calhoun V, Meda SA, Kim J, Mathalon DH, Pearlson GD. PMID: 18031994; PMCID: PMC2668961.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    375. Out-of-synch and out-of-sorts: dysfunction of motor-sensory communication in schizophrenia. Biol Psychiatry. 2008 Apr 15; 63(8):736-43. Ford JM, Roach BJ, Faustman WO, Mathalon DH. PMID: 17981264; PMCID: PMC2330266.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    376. Dissecting corollary discharge dysfunction in schizophrenia. Psychophysiology. 2007 Jul; 44(4):522-9. Ford JM, Gray M, Faustman WO, Roach BJ, Mathalon DH. PMID: 17565658.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    377. Neural synchrony in schizophrenia: from networks to new treatments. Schizophr Bull. 2007 Jul; 33(4):848-52. Ford JM, Krystal JH, Mathalon DH. PMID: 17567628; PMCID: PMC2632315.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    378. Synch before you speak: auditory hallucinations in schizophrenia. Am J Psychiatry. 2007 Mar; 164(3):458-66. Ford JM, Roach BJ, Faustman WO, Mathalon DH. PMID: 17329471.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    379. Relationship of imprecise corollary discharge in schizophrenia to auditory hallucinations. Arch Gen Psychiatry. 2007 Mar; 64(3):286-96. Heinks-Maldonado TH, Mathalon DH, Houde JF, Gray M, Faustman WO, Ford JM. PMID: 17339517.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    380. A functional magnetic resonance imaging study of working memory abnormalities in schizophrenia. Biol Psychiatry. 2006 Jul 01; 60(1):11-21. Johnson MR, Morris NA, Astur RS, Calhoun VD, Mathalon DH, Kiehl KA, Pearlson GD. PMID: 16503328.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    381. Fore-period effect and stop-signal reaction time. Exp Brain Res. 2005 Nov; 167(2):305-9. Li CS, Krystal JH, Mathalon DH. PMID: 16160823.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    382. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry. 2005 Sep 01; 58(5):424-8. Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH. PMID: 15993857.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCTClinical Trials
    383. Corollary discharge dysfunction in schizophrenia: can it explain auditory hallucinations? Int J Psychophysiol. 2005 Nov-Dec; 58(2-3):179-89. Ford JM, Mathalon DH. PMID: 16137779.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    384. Reduced gamma-band coherence to distorted feedback during speech when what you say is not what you hear. Int J Psychophysiol. 2005 Aug; 57(2):143-50. Ford JM, Gray M, Faustman WO, Heinks TH, Mathalon DH. PMID: 15967529.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    385. Delayed hemodynamic responses in schizophrenia. Neuroimage. 2005 Jul 01; 26(3):922-31. Ford JM, Johnson MB, Whitfield SL, Faustman WO, Mathalon DH. PMID: 15955502.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    386. Fine-tuning of auditory cortex during speech production. Psychophysiology. 2005 Mar; 42(2):180-90. Heinks-Maldonado TH, Mathalon DH, Gray M, Ford JM. PMID: 15787855.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    387. Applications of morphometric and diffusion tensor magnetic resonance imaging to the study of brain abnormalities in the alcoholism spectrum. Alcohol Clin Exp Res. 2005 Jan; 29(1):159-166. Daurignac E, Toga A, Jones D, Aronen H, Hommer D, Jemigan T, Krystal J, Mathalon D. PMID: 15895490.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    388. Selective attention in schizophrenia: sparing and loss of executive control. Am J Psychiatry. 2004 May; 161(5):872-81. Mathalon DH, Heinks T, Ford JM. PMID: 15121653.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    389. Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry. 2004 Feb; 61(2):119-29. Ford JM, Gray M, Whitfield SL, Turken AU, Glover G, Faustman WO, Mathalon DH. PMID: 14757588.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    390. Electrophysiological evidence of corollary discharge dysfunction in schizophrenia during talking and thinking. J Psychiatr Res. 2004 Jan; 38(1):37-46. Ford JM, Mathalon DH. PMID: 14690769.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    391. Are impairments of action monitoring and executive control true dissociative dysfunctions in patients with schizophrenia? Am J Psychiatry. 2003 Oct; 160(10):1881-3. Turken AU, Vuilleumier P, Mathalon DH, Swick D, Ford JM. PMID: 14514505.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    392. Anatomy of an error: ERP and fMRI. Biol Psychol. 2003 Oct; 64(1-2):119-41. Mathalon DH, Whitfield SL, Ford JM. PMID: 14602358.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    393. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl). 2003 Sep; 169(3-4):215-33. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R. PMID: 12955285.
      View in: PubMed   Mentions: 207     Fields:    Translation:HumansAnimals
    394. Response-monitoring dysfunction in aging and Alzheimer's disease: an event-related potential study. Neurobiol Aging. 2003 Sep; 24(5):675-85. Mathalon DH, Bennett A, Askari N, Gray EM, Rosenbloom MJ, Ford JM. PMID: 12885575.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    395. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry. Arch Gen Psychiatry. 2003 Aug; 60(8):846-8; author reply 848-9. Mathalon DH, Rapoport JL, Davis KL, Krystal JH. PMID: 12912768.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    396. Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Arch Gen Psychiatry. 2003 Mar; 60(3):245-52. Mathalon DH, Pfefferbaum A, Lim KO, Rosenbloom MJ, Sullivan EV. PMID: 12622657.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    397. N400 and automatic semantic processing abnormalities in patients with schizophrenia. Arch Gen Psychiatry. 2002 Jul; 59(7):641-8. Mathalon DH, Faustman WO, Ford JM. PMID: 12090817.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    398. The long and the short of it: influence of interstimulus interval on auditory P300 abnormalities in schizophrenia. Clin Electroencephalogr. 2002 Jul; 33(3):125-35. Mathalon DH, Ford JM. PMID: 12192662.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    399. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry. 2002 Mar 15; 51(6):485-92. Ford JM, Mathalon DH, Whitfield S, Faustman WO, Roth WT. PMID: 11922884.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    400. Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J Abnorm Psychol. 2002 Feb; 111(1):22-41. Mathalon DH, Fedor M, Faustman WO, Gray M, Askari N, Ford JM. PMID: 11866176.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    401. Neurophysiological evidence of corollary discharge dysfunction in schizophrenia. Am J Psychiatry. 2001 Dec; 158(12):2069-71. Ford JM, Mathalon DH, Heinks T, Kalba S, Faustman WO, Roth WT. PMID: 11729029.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    402. Cortical responsiveness during inner speech in schizophrenia: an event-related potential study. Am J Psychiatry. 2001 Nov; 158(11):1914-6. Ford JM, Mathalon DH, Kalba S, Whitfield S, Faustman WO, Roth WT. PMID: 11691701.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    403. Cortical responsiveness during talking and listening in schizophrenia: an event-related brain potential study. Biol Psychiatry. 2001 Oct 01; 50(7):540-9. Ford JM, Mathalon DH, Kalba S, Whitfield S, Faustman WO, Roth WT. PMID: 11600107.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    404. N1 and P300 abnormalities in patients with schizophrenia, epilepsy, and epilepsy with schizophrenialike features. Biol Psychiatry. 2001 May 15; 49(10):848-60. Ford JM, Mathalon DH, Kalba S, Marsh L, Pfefferbaum A. PMID: 11343681.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    405. Functional neuroanatomy of auditory working memory in schizophrenia: relation to positive and negative symptoms. Neuroimage. 2001 Mar; 13(3):433-46. Menon V, Anagnoson RT, Mathalon DH, Glover GH, Pfefferbaum A. PMID: 11170809.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    406. Event-related brain potential evidence of spared knowledge in Alzheimer's disease. Psychol Aging. 2001 Mar; 16(1):161-76. Ford JM, Askari N, Mathalon DH, Menon V, Gabrieli JD, Tinklenberg JR, Yesavage J. PMID: 11302364.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    407. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2001 Feb; 58(2):148-57. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. PMID: 11177116.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    408. Left temporal deficit of P300 in patients with schizophrenia: effects of task. Int J Psychophysiol. 2000 Oct; 38(1):71-9. Ford JM, Mathalon DH, White PM, Pfefferbaum A. PMID: 11027795.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    409. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Arch Gen Psychiatry. 2000 Sep; 57(9):894-902. Sullivan EV, Deshmukh A, Desmond JE, Mathalon DH, Rosenbloom MJ, Lim KO, Pfefferbaum A. PMID: 10986553.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    410. P300 reduction and prolongation with illness duration in schizophrenia. Biol Psychiatry. 2000 Mar 01; 47(5):413-27. Mathalon DH, Ford JM, Rosenbloom M, Pfefferbaum A. PMID: 10704953.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    411. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol Psychiatry. 2000 Mar 01; 47(5):434-49. Mathalon DH, Ford JM, Pfefferbaum A. PMID: 10704955.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    412. P300 amplitude is related to clinical state in severely and moderately ill patients with schizophrenia. Biol Psychiatry. 1999 Jul 01; 46(1):94-101. Ford JM, Mathalon DH, Marsh L, Faustman WO, Harris D, Hoff AL, Beal M, Pfefferbaum A. PMID: 10394478.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    413. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry. 1998 Oct; 55(10):905-12. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, Mathalon DH, Lim KO. PMID: 9783561.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCTClinical Trials
    414. Association between regional brain volumes and clozapine response in schizophrenia. Biol Psychiatry. 1998 Jun 15; 43(12):879-86. Lauriello J, Mathalon DH, Rosenbloom M, Sullivan EV, Faustman WO, Ringo DL, Lim KO, Pfefferbaum A. PMID: 9627742.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    415. A profile of cortical gray matter volume deficits characteristic of schizophrenia. Cereb Cortex. 1998 Mar; 8(2):117-24. Sullivan EV, Lim KO, Mathalon D, Marsh L, Beal DM, Harris D, Hoff AL, Faustman WO, Pfefferbaum A. PMID: 9542891.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    416. Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholism. Biol Psychiatry. 1998 Jan 15; 43(2):118-31. Sullivan EV, Mathalon DH, Lim KO, Marsh L, Pfefferbaum A. PMID: 9474444.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    417. Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol Clin Exp Res. 1997 05; 21(3):521-9. Pfefferbaum A, Sullivan EV, Mathalon DH, Lim KO. PMID: 9161613.
      View in: PubMed   Mentions: 151     Fields:    Translation:Humans
    418. Relationship between alcohol withdrawal seizures and temporal lobe white matter volume deficits. Alcohol Clin Exp Res. 1996 Apr; 20(2):348-54. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. PMID: 8730229.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    419. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res. 1995 Oct; 19(5):1177-91. Pfefferbaum A, Sullivan EV, Mathalon DH, Shear PK, Rosenbloom MJ, Lim KO. PMID: 8561288.
      View in: PubMed   Mentions: 134     Fields:    Translation:Humans
    420. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging. 1995 Jul-Aug; 16(4):591-606. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. PMID: 8544910.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    421. Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease. Arch Neurol. 1995 Apr; 52(4):392-402. Shear PK, Sullivan EV, Mathalon DH, Lim KO, Davis LF, Yesavage JA, Tinklenberg JR, Pfefferbaum A. PMID: 7710375.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    422. Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics. Alcohol Clin Exp Res. 1995 Feb; 19(1):110-22. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. PMID: 7771636.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    423. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol. 1994 Sep; 51(9):874-87. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. PMID: 8080387.
      View in: PubMed   Mentions: 430     Fields:    Translation:Humans
    424. Increase in brain cerebrospinal fluid volume is greater in older than in younger alcoholic patients: a replication study and CT/MRI comparison. Psychiatry Res. 1993 Dec; 50(4):257-74. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, Shear PK, Mathalon DH, Lim KO. PMID: 8177924.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    425. [Differential therapy for hypertension, hyperlipoproteinemia and diabetes mellitus--individual therapy and interconnections. Wiesbaden, 20 April 1993]. Internist (Berl). 1993 Jul; 34(7 Suppl [differen]):1-8. PMID: 7591609.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    426. Correction for head size in brain-imaging measurements. Psychiatry Res. 1993 Jun; 50(2):121-39. Mathalon DH, Sullivan EV, Rawles JM, Pfefferbaum A. PMID: 8378488.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    427. Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease. Arch Neurol. 1993 Apr; 50(4):359-73. Sullivan EV, Shear PK, Mathalon DH, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A. PMID: 8460957.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    428. Factors of the Wisconsin Card Sorting Test as measures of frontal-lobe function in schizophrenia and in chronic alcoholism. Psychiatry Res. 1993 Feb; 46(2):175-99. Sullivan EV, Mathalon DH, Zipursky RB, Kersteen-Tucker Z, Knight RT, Pfefferbaum A. PMID: 8483976.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    429. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcohol Clin Exp Res. 1992 Dec; 16(6):1078-89. Pfefferbaum A, Lim KO, Zipursky RB, Mathalon DH, Rosenbloom MJ, Lane B, Ha CN, Sullivan EV. PMID: 1471762.
      View in: PubMed   Mentions: 191     Fields:    Translation:Humans
    430. The contribution of constructional accuracy and organizational strategy to nonverbal recall in schizophrenia and chronic alcoholism. Biol Psychiatry. 1992 Aug 15; 32(4):312-33. Sullivan EV, Mathalon DH, Ha CN, Zipursky RB, Pfefferbaum A. PMID: 1420646.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    431. Event-related potentials in alcoholic men: P3 amplitude reflects family history but not alcohol consumption. Alcohol Clin Exp Res. 1991 Oct; 15(5):839-50. Pfefferbaum A, Ford JM, White PM, Mathalon D. PMID: 1755518.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    Daniel's Networks
    Concepts (523)
    Derived automatically from this person's publications.
    _
    Co-Authors (98)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _